| GO Terms | Score | Description |
|---|---|---|
| GO:0008150 | 97.10% | biological_process |
| GO:0065007 | 95.13% | biological regulation |
| GO:0050789 | 95.01% | regulation of biological process |
| GO:0050794 | 94.48% | regulation of cellular process |
| GO:0019222 | 93.60% | regulation of metabolic process |
| GO:0060255 | 93.57% | regulation of macromolecule metabolic process |
| GO:0010468 | 93.37% | regulation of gene expression |
| GO:0080090 | 93.33% | regulation of primary metabolic process |
| GO:0031323 | 93.19% | regulation of cellular metabolic process |
| GO:0019219 | 93.16% | regulation of nucleobase-containing compound metabolic process |
| GO:0051171 | 93.11% | regulation of nitrogen compound metabolic process |
| GO:0009889 | 92.96% | regulation of biosynthetic process |
| GO:0010556 | 92.80% | regulation of macromolecule biosynthetic process |
| GO:0051252 | 92.57% | regulation of RNA metabolic process |
| GO:0031326 | 92.51% | regulation of cellular biosynthetic process |
| GO:1903506 | 92.45% | regulation of nucleic acid-templated transcription |
| GO:2000112 | 92.44% | regulation of cellular macromolecule biosynthetic process |
| GO:0006355 | 92.14% | regulation of transcription, DNA-templated |
| GO:2001141 | 92.11% | regulation of RNA biosynthetic process |
| GO:0032502 | 87.88% | developmental process |
| GO:0006357 | 87.56% | regulation of transcription by RNA polymerase II |
| GO:0009987 | 76.63% | cellular process |
| GO:0048856 | 74.45% | anatomical structure development |
| GO:0048869 | 73.71% | cellular developmental process |
| GO:0009653 | 68.30% | anatomical structure morphogenesis |
| GO:0030154 | 66.27% | cell differentiation |
| GO:0048522 | 61.68% | positive regulation of cellular process |
| GO:0032501 | 61.48% | multicellular organismal process |
| GO:0048518 | 61.32% | positive regulation of biological process |
| GO:0051254 | 58.27% | positive regulation of RNA metabolic process |
| GO:0010557 | 58.21% | positive regulation of macromolecule biosynthetic process |
| GO:0045935 | 58.17% | positive regulation of nucleobase-containing compound metabolic process |
| GO:0010628 | 58.15% | positive regulation of gene expression |
| GO:0009891 | 58.14% | positive regulation of biosynthetic process |
| GO:0031328 | 57.83% | positive regulation of cellular biosynthetic process |
| GO:0051173 | 57.76% | positive regulation of nitrogen compound metabolic process |
| GO:0031325 | 57.37% | positive regulation of cellular metabolic process |
| GO:0010604 | 57.37% | positive regulation of macromolecule metabolic process |
| GO:1902680 | 57.23% | positive regulation of RNA biosynthetic process |
| GO:0048513 | 57.14% | animal organ development |
| GO:1903508 | 57.14% | positive regulation of nucleic acid-templated transcription |
| GO:0045893 | 57.13% | positive regulation of transcription, DNA-templated |
| GO:0009893 | 56.87% | positive regulation of metabolic process |
| GO:0030182 | 55.93% | neuron differentiation |
| GO:0045944 | 54.54% | positive regulation of transcription by RNA polymerase II |
| GO:0048519 | 53.61% | negative regulation of biological process |
| GO:0007389 | 53.10% | pattern specification process |
| GO:0003002 | 52.27% | regionalization |
| GO:0048523 | 51.23% | negative regulation of cellular process |
| GO:0009892 | 45.15% | negative regulation of metabolic process |
| GO:0010629 | 44.75% | negative regulation of gene expression |
| GO:0010605 | 44.61% | negative regulation of macromolecule metabolic process |
| GO:0031324 | 44.55% | negative regulation of cellular metabolic process |
| GO:0010558 | 44.34% | negative regulation of macromolecule biosynthetic process |
| GO:0031327 | 44.02% | negative regulation of cellular biosynthetic process |
| GO:2000113 | 43.99% | negative regulation of cellular macromolecule biosynthetic process |
| GO:0045892 | 43.98% | negative regulation of transcription, DNA-templated |
| GO:1903507 | 43.98% | negative regulation of nucleic acid-templated transcription |
| GO:0009890 | 43.91% | negative regulation of biosynthetic process |
| GO:0051172 | 43.88% | negative regulation of nitrogen compound metabolic process |
| GO:0051253 | 43.73% | negative regulation of RNA metabolic process |
| GO:1902679 | 43.72% | negative regulation of RNA biosynthetic process |
| GO:0045934 | 43.42% | negative regulation of nucleobase-containing compound metabolic process |
| GO:0000122 | 42.94% | negative regulation of transcription by RNA polymerase II |
| GO:0010941 | 41.63% | regulation of cell death |
| GO:0043067 | 41.59% | regulation of programmed cell death |
| GO:0042981 | 41.45% | regulation of apoptotic process |
| GO:0009952 | 41.20% | anterior/posterior pattern specification |
| GO:0048598 | 38.54% | embryonic morphogenesis |
| GO:0043066 | 38.30% | negative regulation of apoptotic process |
| GO:0009887 | 38.07% | animal organ morphogenesis |
| GO:0043069 | 37.93% | negative regulation of programmed cell death |
| GO:0060548 | 37.24% | negative regulation of cell death |
| GO:0006928 | 37.10% | movement of cell or subcellular component |
| GO:0009888 | 36.71% | tissue development |
| GO:0043523 | 35.59% | regulation of neuron apoptotic process |
| GO:1901214 | 34.87% | regulation of neuron death |
| GO:0035239 | 33.61% | tube morphogenesis |
| GO:0043524 | 32.82% | negative regulation of neuron apoptotic process |
| GO:0048729 | 32.63% | tissue morphogenesis |
| GO:0060429 | 32.49% | epithelium development |
| GO:0048468 | 32.24% | cell development |
| GO:1901215 | 32.13% | negative regulation of neuron death |
| GO:0035295 | 31.91% | tube development |
| GO:0002009 | 31.84% | morphogenesis of an epithelium |
| GO:0022414 | 31.77% | reproductive process |
| GO:0003006 | 31.58% | developmental process involved in reproduction |
| GO:0097485 | 30.77% | neuron projection guidance |
| GO:0009886 | 30.34% | post-embryonic animal morphogenesis |
| GO:0007411 | 29.93% | axon guidance |
| GO:0001709 | 28.75% | cell fate determination |
| GO:0048666 | 27.14% | neuron development |
| GO:0030901 | 26.54% | midbrain development |
| GO:0048608 | 26.15% | reproductive structure development |
| GO:0007444 | 26.04% | imaginal disc development |
| GO:0035282 | 25.88% | segmentation |
| GO:0001708 | 25.54% | cell fate specification |
| GO:0060562 | 25.52% | epithelial tube morphogenesis |
| GO:0048563 | 25.36% | post-embryonic animal organ morphogenesis |
| GO:0008406 | 25.08% | gonad development |
| GO:0035107 | 24.62% | appendage morphogenesis |
| GO:0048646 | 24.44% | anatomical structure formation involved in morphogenesis |
| GO:0050896 | 24.44% | response to stimulus |
| GO:0071840 | 22.49% | cellular component organization or biogenesis |
| GO:0016043 | 22.20% | cellular component organization |
| GO:0050793 | 22.15% | regulation of developmental process |
| GO:0051239 | 22.08% | regulation of multicellular organismal process |
| GO:0048731 | 21.56% | system development |
| GO:0048568 | 21.54% | embryonic organ development |
| GO:0042221 | 21.49% | response to chemical |
| GO:0030030 | 21.46% | cell projection organization |
| GO:0048858 | 21.39% | cell projection morphogenesis |
| GO:0120039 | 21.31% | plasma membrane bounded cell projection morphogenesis |
| GO:0048812 | 21.25% | neuron projection morphogenesis |
| GO:0032990 | 21.01% | cell part morphogenesis |
| GO:0032989 | 20.91% | cellular component morphogenesis |
| GO:0010033 | 20.87% | response to organic substance |
| GO:0035108 | 19.36% | limb morphogenesis |
| GO:0030326 | 19.29% | embryonic limb morphogenesis |
| GO:0035113 | 19.12% | embryonic appendage morphogenesis |
| GO:2000026 | 18.32% | regulation of multicellular organismal development |
| GO:0009953 | 17.81% | dorsal/ventral pattern formation |
| GO:0040011 | 17.77% | locomotion |
| GO:0009954 | 17.52% | proximal/distal pattern formation |
| GO:0016477 | 17.36% | cell migration |
| GO:0045595 | 17.04% | regulation of cell differentiation |
| GO:0048870 | 16.75% | cell motility |
| GO:0003008 | 16.56% | system process |
| GO:0040007 | 16.35% | growth |
| GO:0048589 | 16.33% | developmental growth |
| GO:0051240 | 16.28% | positive regulation of multicellular organismal process |
| GO:0048663 | 16.23% | neuron fate commitment |
| GO:0007409 | 16.22% | axonogenesis |
| GO:0051094 | 16.07% | positive regulation of developmental process |
| GO:0030902 | 16.01% | hindbrain development |
| GO:0030855 | 15.86% | epithelial cell differentiation |
| GO:0071542 | 15.80% | dopaminergic neuron differentiation |
| GO:0007423 | 15.68% | sensory organ development |
| GO:0007610 | 15.66% | behavior |
| GO:0042127 | 15.15% | regulation of cell population proliferation |
| GO:0022603 | 14.85% | regulation of anatomical structure morphogenesis |
| GO:0045165 | 14.62% | cell fate commitment |
| GO:0050877 | 14.58% | nervous system process |
| GO:1901700 | 14.53% | response to oxygen-containing compound |
| GO:0043473 | 14.51% | pigmentation |
| GO:0050770 | 14.40% | regulation of axonogenesis |
| GO:0051716 | 14.25% | cellular response to stimulus |
| GO:0010769 | 13.97% | regulation of cell morphogenesis involved in differentiation |
| GO:0051128 | 13.71% | regulation of cellular component organization |
| GO:0007626 | 13.68% | locomotory behavior |
| GO:0022412 | 13.65% | cellular process involved in reproduction in multicellular organism |
| GO:0035115 | 13.61% | embryonic forelimb morphogenesis |
| GO:0014070 | 13.49% | response to organic cyclic compound |
| GO:0048583 | 13.47% | regulation of response to stimulus |
| GO:0022604 | 13.46% | regulation of cell morphogenesis |
| GO:0060284 | 13.32% | regulation of cell development |
| GO:0030534 | 13.25% | adult behavior |
| GO:0035136 | 13.25% | forelimb morphogenesis |
| GO:0021549 | 13.23% | cerebellum development |
| GO:0048665 | 13.15% | neuron fate specification |
| GO:0009719 | 13.15% | response to endogenous stimulus |
| GO:0070887 | 13.08% | cellular response to chemical stimulus |
| GO:0051093 | 13.08% | negative regulation of developmental process |
| GO:0008344 | 13.03% | adult locomotory behavior |
| GO:0007631 | 12.88% | feeding behavior |
| GO:0001763 | 12.74% | morphogenesis of a branching structure |
| GO:0007165 | 12.72% | signal transduction |
| GO:0050767 | 12.59% | regulation of neurogenesis |
| GO:0061138 | 12.57% | morphogenesis of a branching epithelium |
| GO:0051241 | 12.54% | negative regulation of multicellular organismal process |
| GO:0001654 | 12.38% | eye development |
| GO:0048732 | 12.34% | gland development |
| GO:0051704 | 12.32% | multi-organism process |
| GO:0040012 | 12.28% | regulation of locomotion |
| GO:0045597 | 12.22% | positive regulation of cell differentiation |
| GO:0008152 | 12.10% | metabolic process |
| GO:0071310 | 12.09% | cellular response to organic substance |
| GO:0048754 | 11.93% | branching morphogenesis of an epithelial tube |
| GO:0051960 | 11.92% | regulation of nervous system development |
| GO:0009880 | 11.87% | embryonic pattern specification |
| GO:0048584 | 11.78% | positive regulation of response to stimulus |
| GO:0010975 | 11.76% | regulation of neuron projection development |
| GO:0045596 | 11.76% | negative regulation of cell differentiation |
| GO:0010646 | 11.72% | regulation of cell communication |
| GO:0042472 | 11.66% | inner ear morphogenesis |
| GO:0009966 | 11.53% | regulation of signal transduction |
| GO:0023051 | 11.48% | regulation of signaling |
| GO:0008219 | 11.47% | cell death |
| GO:0044237 | 11.42% | cellular metabolic process |
| GO:0048813 | 11.28% | dendrite morphogenesis |
| GO:0045664 | 11.24% | regulation of neuron differentiation |
| GO:0050890 | 11.23% | cognition |
| GO:0051270 | 11.23% | regulation of cellular component movement |
| GO:2000241 | 11.20% | regulation of reproductive process |
| GO:0040008 | 11.19% | regulation of growth |
| GO:0048736 | 11.19% | appendage development |
| GO:0035114 | 11.16% | imaginal disc-derived appendage morphogenesis |
| GO:0001501 | 11.16% | skeletal system development |
| GO:0060541 | 11.09% | respiratory system development |
| GO:0008284 | 11.09% | positive regulation of cell population proliferation |
| GO:0043068 | 11.07% | positive regulation of programmed cell death |
| GO:0007379 | 11.05% | segment specification |
| GO:0007166 | 11.02% | cell surface receptor signaling pathway |
| GO:0007399 | 11.01% | nervous system development |
| GO:0030334 | 11.00% | regulation of cell migration |
| GO:0007275 | 10.98% | multicellular organism development |
| GO:0048863 | 10.95% | stem cell differentiation |
| GO:0010942 | 10.92% | positive regulation of cell death |
| GO:0048638 | 10.90% | regulation of developmental growth |
| GO:0012501 | 10.86% | programmed cell death |
| GO:2000145 | 10.86% | regulation of cell motility |
| GO:0120035 | 10.82% | regulation of plasma membrane bounded cell projection organization |
| GO:0071704 | 10.74% | organic substance metabolic process |
| GO:0042493 | 10.71% | response to drug |
| GO:0002759 | 10.68% | regulation of antimicrobial humoral response |
| GO:0007611 | 10.65% | learning or memory |
| GO:2000243 | 10.64% | positive regulation of reproductive process |
| GO:0002920 | 10.63% | regulation of humoral immune response |
| GO:0034248 | 10.62% | regulation of cellular amide metabolic process |
| GO:0048562 | 10.57% | embryonic organ morphogenesis |
| GO:0002922 | 10.54% | positive regulation of humoral immune response |
| GO:0043170 | 10.43% | macromolecule metabolic process |
| GO:0021953 | 10.43% | central nervous system neuron differentiation |
| GO:0040020 | 10.42% | regulation of meiotic nuclear division |
| GO:0048609 | 10.42% | multicellular organismal reproductive process |
| GO:1901698 | 10.41% | response to nitrogen compound |
| GO:0010647 | 10.39% | positive regulation of cell communication |
| GO:0009967 | 10.39% | positive regulation of signal transduction |
| GO:0048565 | 10.38% | digestive tract development |
| GO:0061061 | 10.38% | muscle structure development |
| GO:0007167 | 10.36% | enzyme linked receptor protein signaling pathway |
| GO:0071495 | 10.35% | cellular response to endogenous stimulus |
| GO:0023056 | 10.34% | positive regulation of signaling |
| GO:0010720 | 10.32% | positive regulation of cell development |
| GO:0010243 | 10.24% | response to organonitrogen compound |
| GO:0035120 | 10.21% | post-embryonic appendage morphogenesis |
| GO:0051705 | 10.21% | multi-organism behavior |
| GO:0051726 | 10.20% | regulation of cell cycle |
| GO:0007612 | 10.20% | learning |
| GO:0002784 | 10.20% | regulation of antimicrobial peptide production |
| GO:0008045 | 10.18% | motor neuron axon guidance |
| GO:0031344 | 10.15% | regulation of cell projection organization |
| GO:0007281 | 10.07% | germ cell development |
| GO:0065008 | 10.04% | regulation of biological quality |
| GO:0061387 | 9.98% | regulation of extent of cell growth |
| GO:1902742 | 9.96% | apoptotic process involved in development |
| GO:0051703 | 9.94% | intraspecies interaction between organisms |
| GO:0032101 | 9.94% | regulation of response to external stimulus |
| GO:0016070 | 9.93% | RNA metabolic process |
| GO:0043065 | 9.89% | positive regulation of apoptotic process |
| GO:0007417 | 9.87% | central nervous system development |
| GO:0007435 | 9.84% | salivary gland morphogenesis |
| GO:0040018 | 9.82% | positive regulation of multicellular organism growth |
| GO:0007420 | 9.79% | brain development |
| GO:0006915 | 9.78% | apoptotic process |
| GO:0007276 | 9.77% | gamete generation |
| GO:0051445 | 9.76% | regulation of meiotic cell cycle |
| GO:0048806 | 9.71% | genitalia development |
| GO:0008283 | 9.70% | cell population proliferation |
| GO:0009410 | 9.70% | response to xenobiotic stimulus |
| GO:0044238 | 9.68% | primary metabolic process |
| GO:0051301 | 9.67% | cell division |
| GO:0046483 | 9.65% | heterocycle metabolic process |
| GO:0006725 | 9.64% | cellular aromatic compound metabolic process |
| GO:0072347 | 9.61% | response to anesthetic |
| GO:0033043 | 9.58% | regulation of organelle organization |
| GO:0001503 | 9.56% | ossification |
| GO:0042659 | 9.51% | regulation of cell fate specification |
| GO:0051216 | 9.51% | cartilage development |
| GO:0060359 | 9.47% | response to ammonium ion |
| GO:0034250 | 9.45% | positive regulation of cellular amide metabolic process |
| GO:0045927 | 9.44% | positive regulation of growth |
| GO:0030516 | 9.43% | regulation of axon extension |
| GO:0044249 | 9.39% | cellular biosynthetic process |
| GO:1901360 | 9.33% | organic cyclic compound metabolic process |
| GO:0022612 | 9.33% | gland morphogenesis |
| GO:0002064 | 9.32% | epithelial cell development |
| GO:0009725 | 9.31% | response to hormone |
| GO:1901576 | 9.26% | organic substance biosynthetic process |
| GO:0070848 | 9.20% | response to growth factor |
| GO:0009058 | 9.20% | biosynthetic process |
| GO:0042220 | 9.20% | response to cocaine |
| GO:0051785 | 9.19% | positive regulation of nuclear division |
| GO:0045836 | 9.18% | positive regulation of meiotic nuclear division |
| GO:0034641 | 9.18% | cellular nitrogen compound metabolic process |
| GO:0006139 | 9.13% | nucleobase-containing compound metabolic process |
| GO:0009948 | 9.11% | anterior/posterior axis specification |
| GO:0032879 | 9.09% | regulation of localization |
| GO:0009798 | 9.08% | axis specification |
| GO:0051446 | 9.06% | positive regulation of meiotic cell cycle |
| GO:0007530 | 9.06% | sex determination |
| GO:0090304 | 9.04% | nucleic acid metabolic process |
| GO:0007292 | 9.04% | female gamete generation |
| GO:0010564 | 9.02% | regulation of cell cycle process |
| GO:0071363 | 9.02% | cellular response to growth factor stimulus |
| GO:0048477 | 9.01% | oogenesis |
| GO:0048705 | 8.97% | skeletal system morphogenesis |
| GO:0006807 | 8.93% | nitrogen compound metabolic process |
| GO:0001558 | 8.88% | regulation of cell growth |
| GO:0032774 | 8.87% | RNA biosynthetic process |
| GO:1901362 | 8.86% | organic cyclic compound biosynthetic process |
| GO:0048704 | 8.83% | embryonic skeletal system morphogenesis |
| GO:0018130 | 8.83% | heterocycle biosynthetic process |
| GO:0035176 | 8.83% | social behavior |
| GO:0008038 | 8.81% | neuron recognition |
| GO:0051962 | 8.76% | positive regulation of nervous system development |
| GO:0010770 | 8.75% | positive regulation of cell morphogenesis involved in differentiation |
| GO:0035264 | 8.74% | multicellular organism growth |
| GO:0048639 | 8.73% | positive regulation of developmental growth |
| GO:0009059 | 8.71% | macromolecule biosynthetic process |
| GO:0051130 | 8.70% | positive regulation of cellular component organization |
| GO:0045787 | 8.69% | positive regulation of cell cycle |
| GO:0050769 | 8.69% | positive regulation of neurogenesis |
| GO:0019438 | 8.68% | aromatic compound biosynthetic process |
| GO:0051783 | 8.66% | regulation of nuclear division |
| GO:0009605 | 8.62% | response to external stimulus |
| GO:0010453 | 8.56% | regulation of cell fate commitment |
| GO:0002682 | 8.56% | regulation of immune system process |
| GO:0007600 | 8.55% | sensory perception |
| GO:0034654 | 8.53% | nucleobase-containing compound biosynthetic process |
| GO:0001649 | 8.51% | osteoblast differentiation |
| GO:0044260 | 8.48% | cellular macromolecule metabolic process |
| GO:0007519 | 8.47% | skeletal muscle tissue development |
| GO:0043279 | 8.45% | response to alkaloid |
| GO:0060349 | 8.44% | bone morphogenesis |
| GO:0021885 | 8.43% | forebrain cell migration |
| GO:0090068 | 8.43% | positive regulation of cell cycle process |
| GO:0021954 | 8.37% | central nervous system neuron development |
| GO:0044271 | 8.37% | cellular nitrogen compound biosynthetic process |
| GO:0030509 | 8.34% | BMP signaling pathway |
| GO:0061458 | 8.34% | reproductive system development |
| GO:0030856 | 8.29% | regulation of epithelial cell differentiation |
| GO:0010721 | 8.28% | negative regulation of cell development |
| GO:0008037 | 8.27% | cell recognition |
| GO:0045995 | 8.27% | regulation of embryonic development |
| GO:2000177 | 8.26% | regulation of neural precursor cell proliferation |
| GO:0097659 | 8.26% | nucleic acid-templated transcription |
| GO:0007178 | 8.26% | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0021795 | 8.23% | cerebral cortex cell migration |
| GO:0010638 | 8.21% | positive regulation of organelle organization |
| GO:0060537 | 8.20% | muscle tissue development |
| GO:0009628 | 8.15% | response to abiotic stimulus |
| GO:0007476 | 8.10% | imaginal disc-derived wing morphogenesis |
| GO:0042461 | 8.09% | photoreceptor cell development |
| GO:0034645 | 8.07% | cellular macromolecule biosynthetic process |
| GO:0006351 | 8.06% | transcription, DNA-templated |
| GO:0045926 | 7.99% | negative regulation of growth |
| GO:0002831 | 7.99% | regulation of response to biotic stimulus |
| GO:0045666 | 7.98% | positive regulation of neuron differentiation |
| GO:0043902 | 7.96% | positive regulation of multi-organism process |
| GO:0048592 | 7.94% | eye morphogenesis |
| GO:0022029 | 7.92% | telencephalon cell migration |
| GO:0010632 | 7.89% | regulation of epithelial cell migration |
| GO:0007507 | 7.87% | heart development |
| GO:0046530 | 7.87% | photoreceptor cell differentiation |
| GO:0090596 | 7.86% | sensory organ morphogenesis |
| GO:0042462 | 7.84% | eye photoreceptor cell development |
| GO:0035148 | 7.84% | tube formation |
| GO:1902667 | 7.82% | regulation of axon guidance |
| GO:0007619 | 7.81% | courtship behavior |
| GO:0010623 | 7.80% | programmed cell death involved in cell development |
| GO:0060325 | 7.80% | face morphogenesis |
| GO:0050768 | 7.79% | negative regulation of neurogenesis |
| GO:0010001 | 7.73% | glial cell differentiation |
| GO:0006950 | 7.72% | response to stress |
| GO:0043010 | 7.69% | camera-type eye development |
| GO:0031018 | 7.66% | endocrine pancreas development |
| GO:0002833 | 7.63% | positive regulation of response to biotic stimulus |
| GO:0098727 | 7.61% | maintenance of cell number |
| GO:0008285 | 7.60% | negative regulation of cell population proliferation |
| GO:0051090 | 7.59% | regulation of DNA-binding transcription factor activity |
| GO:0002066 | 7.56% | columnar/cuboidal epithelial cell development |
| GO:0060021 | 7.52% | roof of mouth development |
| GO:0065009 | 7.52% | regulation of molecular function |
| GO:0007422 | 7.51% | peripheral nervous system development |
| GO:0007498 | 7.48% | mesoderm development |
| GO:0019827 | 7.47% | stem cell population maintenance |
| GO:0007346 | 7.46% | regulation of mitotic cell cycle |
| GO:0007548 | 7.44% | sex differentiation |
| GO:0045835 | 7.43% | negative regulation of meiotic nuclear division |
| GO:0022607 | 7.35% | cellular component assembly |
| GO:0042476 | 7.34% | odontogenesis |
| GO:0043900 | 7.32% | regulation of multi-organism process |
| GO:0060173 | 7.31% | limb development |
| GO:1901522 | 7.31% | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus |
| GO:0007154 | 7.30% | cell communication |
| GO:0014706 | 7.29% | striated muscle tissue development |
| GO:0042592 | 7.28% | homeostatic process |
| GO:0051179 | 7.27% | localization |
| GO:0001764 | 7.26% | neuron migration |
| GO:0035137 | 7.26% | hindlimb morphogenesis |
| GO:0008544 | 7.24% | epidermis development |
| GO:0045931 | 7.23% | positive regulation of mitotic cell cycle |
| GO:0030335 | 7.21% | positive regulation of cell migration |
| GO:0030111 | 7.20% | regulation of Wnt signaling pathway |
| GO:0010631 | 7.19% | epithelial cell migration |
| GO:0050920 | 7.17% | regulation of chemotaxis |
| GO:0032103 | 7.17% | positive regulation of response to external stimulus |
| GO:0002684 | 7.16% | positive regulation of immune system process |
| GO:0061919 | 7.12% | process utilizing autophagic mechanism |
| GO:2000027 | 7.10% | regulation of animal organ morphogenesis |
| GO:0007517 | 7.09% | muscle organ development |
| GO:1905879 | 7.09% | regulation of oogenesis |
| GO:0036075 | 7.09% | replacement ossification |
| GO:0040014 | 7.07% | regulation of multicellular organism growth |
| GO:0001958 | 7.06% | endochondral ossification |
| GO:0030308 | 7.05% | negative regulation of cell growth |
| GO:2000178 | 6.99% | negative regulation of neural precursor cell proliferation |
| GO:0006996 | 6.98% | organelle organization |
| GO:0007492 | 6.97% | endoderm development |
| GO:0051961 | 6.97% | negative regulation of nervous system development |
| GO:0007617 | 6.97% | mating behavior |
| GO:0061448 | 6.97% | connective tissue development |
| GO:0072175 | 6.97% | epithelial tube formation |
| GO:0030278 | 6.97% | regulation of ossification |
| GO:0010634 | 6.93% | positive regulation of epithelial cell migration |
| GO:0050678 | 6.93% | regulation of epithelial cell proliferation |
| GO:2000147 | 6.91% | positive regulation of cell motility |
| GO:0033993 | 6.91% | response to lipid |
| GO:0040017 | 6.90% | positive regulation of locomotion |
| GO:0001667 | 6.86% | ameboidal-type cell migration |
| GO:0002702 | 6.85% | positive regulation of production of molecular mediator of immune response |
| GO:0050679 | 6.84% | positive regulation of epithelial cell proliferation |
| GO:0060322 | 6.84% | head development |
| GO:0120036 | 6.83% | plasma membrane bounded cell projection organization |
| GO:0021782 | 6.81% | glial cell development |
| GO:1900426 | 6.79% | positive regulation of defense response to bacterium |
| GO:0060560 | 6.78% | developmental growth involved in morphogenesis |
| GO:0014013 | 6.77% | regulation of gliogenesis |
| GO:0060179 | 6.74% | male mating behavior |
| GO:1900424 | 6.74% | regulation of defense response to bacterium |
| GO:0006914 | 6.70% | autophagy |
| GO:0032870 | 6.70% | cellular response to hormone stimulus |
| GO:0048534 | 6.69% | hematopoietic or lymphoid organ development |
| GO:0010817 | 6.69% | regulation of hormone levels |
| GO:0008589 | 6.66% | regulation of smoothened signaling pathway |
| GO:0002699 | 6.66% | positive regulation of immune effector process |
| GO:0016049 | 6.65% | cell growth |
| GO:0051272 | 6.65% | positive regulation of cellular component movement |
| GO:0032355 | 6.64% | response to estradiol |
| GO:0007297 | 6.64% | ovarian follicle cell migration |
| GO:0071772 | 6.63% | response to BMP |
| GO:0021533 | 6.63% | cell differentiation in hindbrain |
| GO:0031667 | 6.61% | response to nutrient levels |
| GO:0030858 | 6.58% | positive regulation of epithelial cell differentiation |
| GO:0048701 | 6.57% | embryonic cranial skeleton morphogenesis |
| GO:0002065 | 6.57% | columnar/cuboidal epithelial cell differentiation |
| GO:0007588 | 6.57% | excretion |
| GO:0071773 | 6.56% | cellular response to BMP stimulus |
| GO:0035112 | 6.56% | genitalia morphogenesis |
| GO:0090092 | 6.54% | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0010639 | 6.54% | negative regulation of organelle organization |
| GO:0072009 | 6.53% | nephron epithelium development |
| GO:0051641 | 6.53% | cellular localization |
| GO:0002088 | 6.52% | lens development in camera-type eye |
| GO:0048232 | 6.49% | male gamete generation |
| GO:0030900 | 6.46% | forebrain development |
| GO:2000242 | 6.46% | negative regulation of reproductive process |
| GO:0045685 | 6.44% | regulation of glial cell differentiation |
| GO:0030177 | 6.41% | positive regulation of Wnt signaling pathway |
| GO:0006366 | 6.40% | transcription by RNA polymerase II |
| GO:0001704 | 6.36% | formation of primary germ layer |
| GO:0051234 | 6.36% | establishment of localization |
| GO:0009790 | 6.35% | embryo development |
| GO:0031016 | 6.32% | pancreas development |
| GO:0001658 | 6.28% | branching involved in ureteric bud morphogenesis |
| GO:0008584 | 6.27% | male gonad development |
| GO:0045665 | 6.25% | negative regulation of neuron differentiation |
| GO:0030097 | 6.22% | hemopoiesis |
| GO:0006810 | 6.21% | transport |
| GO:0002700 | 6.20% | regulation of production of molecular mediator of immune response |
| GO:0048839 | 6.18% | inner ear development |
| GO:0060828 | 6.16% | regulation of canonical Wnt signaling pathway |
| GO:0051784 | 6.16% | negative regulation of nuclear division |
| GO:0072073 | 6.16% | kidney epithelium development |
| GO:0021983 | 6.16% | pituitary gland development |
| GO:0040019 | 6.15% | positive regulation of embryonic development |
| GO:0048864 | 6.15% | stem cell development |
| GO:0045667 | 6.14% | regulation of osteoblast differentiation |
| GO:0008366 | 6.13% | axon ensheathment |
| GO:0070925 | 6.12% | organelle assembly |
| GO:0050954 | 6.12% | sensory perception of mechanical stimulus |
| GO:0043433 | 6.11% | negative regulation of DNA-binding transcription factor activity |
| GO:0006417 | 6.10% | regulation of translation |
| GO:0007413 | 6.09% | axonal fasciculation |
| GO:0045765 | 6.07% | regulation of angiogenesis |
| GO:0044057 | 6.07% | regulation of system process |
| GO:0009792 | 6.07% | embryo development ending in birth or egg hatching |
| GO:0045880 | 6.07% | positive regulation of smoothened signaling pathway |
| GO:0045778 | 6.05% | positive regulation of ossification |
| GO:0007283 | 6.04% | spermatogenesis |
| GO:0007416 | 6.03% | synapse assembly |
| GO:0001568 | 6.02% | blood vessel development |
| GO:0042552 | 6.02% | myelination |
| GO:0014015 | 6.01% | positive regulation of gliogenesis |
| GO:1901342 | 6.00% | regulation of vasculature development |
| GO:0051447 | 5.99% | negative regulation of meiotic cell cycle |
| GO:2000677 | 5.98% | regulation of transcription regulatory region DNA binding |
| GO:0030307 | 5.96% | positive regulation of cell growth |
| GO:0045669 | 5.96% | positive regulation of osteoblast differentiation |
| GO:0007605 | 5.93% | sensory perception of sound |
| GO:0090287 | 5.92% | regulation of cellular response to growth factor stimulus |
| GO:0061005 | 5.92% | cell differentiation involved in kidney development |
| GO:0007272 | 5.92% | ensheathment of neurons |
| GO:0045687 | 5.91% | positive regulation of glial cell differentiation |
| GO:0010608 | 5.91% | posttranscriptional regulation of gene expression |
| GO:0045840 | 5.89% | positive regulation of mitotic nuclear division |
| GO:0032330 | 5.89% | regulation of chondrocyte differentiation |
| GO:0106030 | 5.88% | neuron projection fasciculation |
| GO:0035088 | 5.88% | establishment or maintenance of apical/basal cell polarity |
| GO:0009991 | 5.86% | response to extracellular stimulus |
| GO:0007163 | 5.86% | establishment or maintenance of cell polarity |
| GO:0048857 | 5.85% | neural nucleus development |
| GO:0050953 | 5.84% | sensory perception of light stimulus |
| GO:0046620 | 5.84% | regulation of organ growth |
| GO:0048878 | 5.83% | chemical homeostasis |
| GO:0035116 | 5.83% | embryonic hindlimb morphogenesis |
| GO:0090183 | 5.82% | regulation of kidney development |
| GO:0033036 | 5.82% | macromolecule localization |
| GO:0008356 | 5.80% | asymmetric cell division |
| GO:0000902 | 5.80% | cell morphogenesis |
| GO:0099537 | 5.80% | trans-synaptic signaling |
| GO:0030878 | 5.78% | thyroid gland development |
| GO:0061035 | 5.77% | regulation of cartilage development |
| GO:0002697 | 5.76% | regulation of immune effector process |
| GO:0061245 | 5.76% | establishment or maintenance of bipolar cell polarity |
| GO:0008340 | 5.75% | determination of adult lifespan |
| GO:0090263 | 5.74% | positive regulation of canonical Wnt signaling pathway |
| GO:0060563 | 5.74% | neuroepithelial cell differentiation |
| GO:0007622 | 5.73% | rhythmic behavior |
| GO:0045184 | 5.72% | establishment of protein localization |
| GO:0006338 | 5.71% | chromatin remodeling |
| GO:0001822 | 5.71% | kidney development |
| GO:0007601 | 5.71% | visual perception |
| GO:0060688 | 5.70% | regulation of morphogenesis of a branching structure |
| GO:0042330 | 5.70% | taxis |
| GO:0040034 | 5.70% | regulation of development, heterochronic |
| GO:0050776 | 5.69% | regulation of immune response |
| GO:0031669 | 5.68% | cellular response to nutrient levels |
| GO:0042060 | 5.68% | wound healing |
| GO:0030324 | 5.64% | lung development |
| GO:0007268 | 5.64% | chemical synaptic transmission |
| GO:0023052 | 5.64% | signaling |
| GO:0048511 | 5.64% | rhythmic process |
| GO:0050778 | 5.62% | positive regulation of immune response |
| GO:0060631 | 5.62% | regulation of meiosis I |
| GO:0042733 | 5.59% | embryonic digit morphogenesis |
| GO:0048588 | 5.59% | developmental cell growth |
| GO:0090598 | 5.59% | male anatomical structure morphogenesis |
| GO:0045727 | 5.57% | positive regulation of translation |
| GO:0009611 | 5.56% | response to wounding |
| GO:0045684 | 5.56% | positive regulation of epidermis development |
| GO:0022402 | 5.56% | cell cycle process |
| GO:0048709 | 5.55% | oligodendrocyte differentiation |
| GO:0045682 | 5.54% | regulation of epidermis development |
| GO:0007169 | 5.54% | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0090184 | 5.53% | positive regulation of kidney development |
| GO:0051271 | 5.51% | negative regulation of cellular component movement |
| GO:0010470 | 5.51% | regulation of gastrulation |
| GO:0051101 | 5.50% | regulation of DNA binding |
| GO:2001222 | 5.50% | regulation of neuron migration |
| GO:0007088 | 5.47% | regulation of mitotic nuclear division |
| GO:0008104 | 5.47% | protein localization |
| GO:0060041 | 5.46% | retina development in camera-type eye |
| GO:0099536 | 5.45% | synaptic signaling |
| GO:0031346 | 5.44% | positive regulation of cell projection organization |
| GO:0071392 | 5.42% | cellular response to estradiol stimulus |
| GO:0035265 | 5.41% | organ growth |
| GO:0019098 | 5.41% | reproductive behavior |
| GO:0048569 | 5.39% | post-embryonic animal organ development |
| GO:0051129 | 5.38% | negative regulation of cellular component organization |
| GO:0009791 | 5.38% | post-embryonic development |
| GO:0010467 | 5.38% | gene expression |
| GO:0051054 | 5.38% | positive regulation of DNA metabolic process |
| GO:0007267 | 5.37% | cell-cell signaling |
| GO:0048585 | 5.35% | negative regulation of response to stimulus |
| GO:0008347 | 5.34% | glial cell migration |
| GO:1902692 | 5.34% | regulation of neuroblast proliferation |
| GO:0000578 | 5.34% | embryonic axis specification |
| GO:0045604 | 5.32% | regulation of epidermal cell differentiation |
| GO:1901701 | 5.31% | cellular response to oxygen-containing compound |
| GO:0098916 | 5.31% | anterograde trans-synaptic signaling |
| GO:0061217 | 5.30% | regulation of mesonephros development |
| GO:0060485 | 5.30% | mesenchyme development |
| GO:0110111 | 5.28% | negative regulation of animal organ morphogenesis |
| GO:0051098 | 5.26% | regulation of binding |
| GO:1901343 | 5.24% | negative regulation of vasculature development |
| GO:0015833 | 5.23% | peptide transport |
| GO:0007369 | 5.20% | gastrulation |
| GO:0030216 | 5.20% | keratinocyte differentiation |
| GO:0035019 | 5.20% | somatic stem cell population maintenance |
| GO:0061351 | 5.20% | neural precursor cell proliferation |
| GO:0010976 | 5.19% | positive regulation of neuron projection development |
| GO:0031668 | 5.18% | cellular response to extracellular stimulus |
| GO:0070482 | 5.17% | response to oxygen levels |
| GO:0071407 | 5.16% | cellular response to organic cyclic compound |
| GO:0050772 | 5.16% | positive regulation of axonogenesis |
| GO:0051246 | 5.14% | regulation of protein metabolic process |
| GO:0040028 | 5.12% | regulation of vulval development |
| GO:0046907 | 5.11% | intracellular transport |
| GO:0072331 | 5.09% | signal transduction by p53 class mediator |
| GO:0016331 | 5.09% | morphogenesis of embryonic epithelium |
| GO:0036293 | 5.08% | response to decreased oxygen levels |
| GO:0001889 | 5.08% | liver development |
| GO:2000181 | 5.07% | negative regulation of blood vessel morphogenesis |
| GO:2000146 | 5.07% | negative regulation of cell motility |
| GO:0044092 | 5.06% | negative regulation of molecular function |
| GO:0032268 | 5.06% | regulation of cellular protein metabolic process |
| GO:0009743 | 5.05% | response to carbohydrate |
| GO:0051049 | 5.05% | regulation of transport |
| GO:0051052 | 5.03% | regulation of DNA metabolic process |
| GO:0044093 | 5.03% | positive regulation of molecular function |
| GO:0009629 | 5.00% | response to gravity |
| GO:0045197 | 4.99% | establishment or maintenance of epithelial cell apical/basal polarity |
| GO:0034284 | 4.99% | response to monosaccharide |
| GO:0071345 | 4.98% | cellular response to cytokine stimulus |
| GO:0048713 | 4.97% | regulation of oligodendrocyte differentiation |
| GO:0048675 | 4.97% | axon extension |
| GO:0060249 | 4.95% | anatomical structure homeostasis |
| GO:0009566 | 4.94% | fertilization |
| GO:0007528 | 4.94% | neuromuscular junction development |
| GO:0002053 | 4.94% | positive regulation of mesenchymal cell proliferation |
| GO:0006261 | 4.94% | DNA-dependent DNA replication |
| GO:0009749 | 4.94% | response to glucose |
| GO:0045616 | 4.93% | regulation of keratinocyte differentiation |
| GO:0007338 | 4.92% | single fertilization |
| GO:0031175 | 4.91% | neuron projection development |
| GO:0022008 | 4.91% | neurogenesis |
| GO:0030336 | 4.91% | negative regulation of cell migration |
| GO:0042886 | 4.90% | amide transport |
| GO:0009913 | 4.90% | epidermal cell differentiation |
| GO:0006325 | 4.90% | chromatin organization |
| GO:0051050 | 4.90% | positive regulation of transport |
| GO:0042475 | 4.88% | odontogenesis of dentin-containing tooth |
| GO:0015031 | 4.88% | protein transport |
| GO:0034249 | 4.88% | negative regulation of cellular amide metabolic process |
| GO:0045773 | 4.88% | positive regulation of axon extension |
| GO:0048762 | 4.86% | mesenchymal cell differentiation |
| GO:0060479 | 4.86% | lung cell differentiation |
| GO:0048514 | 4.85% | blood vessel morphogenesis |
| GO:0080134 | 4.84% | regulation of response to stress |
| GO:0051302 | 4.83% | regulation of cell division |
| GO:0033554 | 4.83% | cellular response to stress |
| GO:0016525 | 4.82% | negative regulation of angiogenesis |
| GO:0040013 | 4.82% | negative regulation of locomotion |
| GO:0097305 | 4.81% | response to alcohol |
| GO:0017148 | 4.81% | negative regulation of translation |
| GO:0007034 | 4.80% | vacuolar transport |
| GO:1905939 | 4.79% | regulation of gonad development |
| GO:0071705 | 4.79% | nitrogen compound transport |
| GO:0035051 | 4.79% | cardiocyte differentiation |
| GO:0048582 | 4.77% | positive regulation of post-embryonic development |
| GO:0061062 | 4.77% | regulation of nematode larval development |
| GO:0034097 | 4.77% | response to cytokine |
| GO:0048536 | 4.76% | spleen development |
| GO:0006972 | 4.75% | hyperosmotic response |
| GO:0071702 | 4.75% | organic substance transport |
| GO:0009416 | 4.75% | response to light stimulus |
| GO:0110110 | 4.74% | positive regulation of animal organ morphogenesis |
| GO:0009746 | 4.74% | response to hexose |
| GO:0072091 | 4.73% | regulation of stem cell proliferation |
| GO:0021675 | 4.72% | nerve development |
| GO:0010594 | 4.71% | regulation of endothelial cell migration |
| GO:0043933 | 4.71% | protein-containing complex subunit organization |
| GO:0001666 | 4.70% | response to hypoxia |
| GO:0051493 | 4.69% | regulation of cytoskeleton organization |
| GO:0021766 | 4.69% | hippocampus development |
| GO:0032784 | 4.68% | regulation of DNA-templated transcription, elongation |
| GO:0071496 | 4.68% | cellular response to external stimulus |
| GO:0016050 | 4.68% | vesicle organization |
| GO:0001894 | 4.67% | tissue homeostasis |
| GO:0009314 | 4.64% | response to radiation |
| GO:0021537 | 4.63% | telencephalon development |
| GO:0070727 | 4.63% | cellular macromolecule localization |
| GO:0060341 | 4.62% | regulation of cellular localization |
| GO:0042538 | 4.62% | hyperosmotic salinity response |
| GO:0030510 | 4.62% | regulation of BMP signaling pathway |
| GO:2000736 | 4.61% | regulation of stem cell differentiation |
| GO:0051169 | 4.61% | nuclear transport |
| GO:0044782 | 4.60% | cilium organization |
| GO:0003044 | 4.59% | regulation of systemic arterial blood pressure mediated by a chemical signal |
| GO:0007219 | 4.59% | Notch signaling pathway |
| GO:0006913 | 4.58% | nucleocytoplasmic transport |
| GO:1903706 | 4.58% | regulation of hemopoiesis |
| GO:0001990 | 4.58% | regulation of systemic arterial blood pressure by hormone |
| GO:0042752 | 4.58% | regulation of circadian rhythm |
| GO:0050773 | 4.57% | regulation of dendrite development |
| GO:0031670 | 4.57% | cellular response to nutrient |
| GO:0050795 | 4.57% | regulation of behavior |
| GO:0045599 | 4.56% | negative regulation of fat cell differentiation |
| GO:0008543 | 4.56% | fibroblast growth factor receptor signaling pathway |
| GO:0032880 | 4.56% | regulation of protein localization |
| GO:2000179 | 4.56% | positive regulation of neural precursor cell proliferation |
| GO:0002683 | 4.54% | negative regulation of immune system process |
| GO:0071396 | 4.54% | cellular response to lipid |
| GO:0042445 | 4.54% | hormone metabolic process |
| GO:0060047 | 4.54% | heart contraction |
| GO:0034622 | 4.53% | cellular protein-containing complex assembly |
| GO:0016055 | 4.52% | Wnt signaling pathway |
| GO:0048753 | 4.52% | pigment granule organization |
| GO:0008585 | 4.52% | female gonad development |
| GO:0048469 | 4.50% | cell maturation |
| GO:0048844 | 4.49% | artery morphogenesis |
| GO:1901880 | 4.49% | negative regulation of protein depolymerization |
| GO:0002376 | 4.48% | immune system process |
| GO:0006333 | 4.48% | chromatin assembly or disassembly |
| GO:0021545 | 4.48% | cranial nerve development |
| GO:0021515 | 4.48% | cell differentiation in spinal cord |
| GO:0044255 | 4.46% | cellular lipid metabolic process |
| GO:0048871 | 4.46% | multicellular organismal homeostasis |
| GO:0044087 | 4.45% | regulation of cellular component biogenesis |
| GO:0090087 | 4.45% | regulation of peptide transport |
| GO:0050878 | 4.45% | regulation of body fluid levels |
| GO:0071695 | 4.44% | anatomical structure maturation |
| GO:0008582 | 4.43% | regulation of synaptic growth at neuromuscular junction |
| GO:0010810 | 4.42% | regulation of cell-substrate adhesion |
| GO:0010464 | 4.40% | regulation of mesenchymal cell proliferation |
| GO:0006886 | 4.40% | intracellular protein transport |
| GO:0090100 | 4.39% | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0006260 | 4.39% | DNA replication |
| GO:1905330 | 4.38% | regulation of morphogenesis of an epithelium |
| GO:0051099 | 4.38% | positive regulation of binding |
| GO:1905114 | 4.38% | cell surface receptor signaling pathway involved in cell-cell signaling |
| GO:1901654 | 4.37% | response to ketone |
| GO:1904396 | 4.36% | regulation of neuromuscular junction development |
| GO:1990138 | 4.34% | neuron projection extension |
| GO:0071824 | 4.34% | protein-DNA complex subunit organization |
| GO:1903708 | 4.34% | positive regulation of hemopoiesis |
| GO:0001952 | 4.32% | regulation of cell-matrix adhesion |
| GO:0009639 | 4.32% | response to red or far red light |
| GO:0046622 | 4.32% | positive regulation of organ growth |
| GO:0001837 | 4.31% | epithelial to mesenchymal transition |
| GO:0065004 | 4.31% | protein-DNA complex assembly |
| GO:0031347 | 4.30% | regulation of defense response |
| GO:0001656 | 4.30% | metanephros development |
| GO:0071684 | 4.29% | organism emergence from protective structure |
| GO:0030011 | 4.28% | maintenance of cell polarity |
| GO:0048512 | 4.28% | circadian behavior |
| GO:0009855 | 4.28% | determination of bilateral symmetry |
| GO:0009968 | 4.26% | negative regulation of signal transduction |
| GO:0003013 | 4.26% | circulatory system process |
| GO:0048706 | 4.26% | embryonic skeletal system development |
| GO:0007623 | 4.26% | circadian rhythm |
| GO:0048640 | 4.26% | negative regulation of developmental growth |
| GO:0007368 | 4.26% | determination of left/right symmetry |
| GO:0044786 | 4.25% | cell cycle DNA replication |
| GO:0043535 | 4.24% | regulation of blood vessel endothelial cell migration |
| GO:0050808 | 4.24% | synapse organization |
| GO:0050886 | 4.22% | endocrine process |
| GO:0048814 | 4.22% | regulation of dendrite morphogenesis |
| GO:0043388 | 4.22% | positive regulation of DNA binding |
| GO:0032269 | 4.20% | negative regulation of cellular protein metabolic process |
| GO:0070201 | 4.20% | regulation of establishment of protein localization |
| GO:0033365 | 4.20% | protein localization to organelle |
| GO:0033044 | 4.20% | regulation of chromosome organization |
| GO:0032968 | 4.19% | positive regulation of transcription elongation from RNA polymerase II promoter |
| GO:1901879 | 4.19% | regulation of protein depolymerization |
| GO:0007584 | 4.19% | response to nutrient |
| GO:0043207 | 4.19% | response to external biotic stimulus |
| GO:1903859 | 4.19% | regulation of dendrite extension |
| GO:0055001 | 4.18% | muscle cell development |
| GO:0045475 | 4.18% | locomotor rhythm |
| GO:0006644 | 4.16% | phospholipid metabolic process |
| GO:0001890 | 4.15% | placenta development |
| GO:0048103 | 4.14% | somatic stem cell division |
| GO:0009826 | 4.14% | unidimensional cell growth |
| GO:0060612 | 4.13% | adipose tissue development |
| GO:0007586 | 4.13% | digestion |
| GO:0042593 | 4.12% | glucose homeostasis |
| GO:0035556 | 4.12% | intracellular signal transduction |
| GO:0030857 | 4.12% | negative regulation of epithelial cell differentiation |
| GO:0035050 | 4.11% | embryonic heart tube development |
| GO:0042692 | 4.09% | muscle cell differentiation |
| GO:0045598 | 4.08% | regulation of fat cell differentiation |
| GO:0051248 | 4.08% | negative regulation of protein metabolic process |
| GO:0033500 | 4.07% | carbohydrate homeostasis |
| GO:0010648 | 4.07% | negative regulation of cell communication |
| GO:0072332 | 4.06% | intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:0034243 | 4.06% | regulation of transcription elongation from RNA polymerase II promoter |
| GO:0048872 | 4.06% | homeostasis of number of cells |
| GO:0007606 | 4.05% | sensory perception of chemical stimulus |
| GO:0060070 | 4.05% | canonical Wnt signaling pathway |
| GO:0090066 | 4.05% | regulation of anatomical structure size |
| GO:0065003 | 4.05% | protein-containing complex assembly |
| GO:0051223 | 4.04% | regulation of protein transport |
| GO:1903861 | 4.04% | positive regulation of dendrite extension |
| GO:0097193 | 4.02% | intrinsic apoptotic signaling pathway |
| GO:0060271 | 4.02% | cilium assembly |
| GO:0009799 | 4.01% | specification of symmetry |
| GO:1902275 | 4.01% | regulation of chromatin organization |
| GO:0031114 | 4.01% | regulation of microtubule depolymerization |
| GO:0023057 | 4.01% | negative regulation of signaling |
| GO:0008016 | 3.99% | regulation of heart contraction |
| GO:0045639 | 3.99% | positive regulation of myeloid cell differentiation |
| GO:1901989 | 3.99% | positive regulation of cell cycle phase transition |
| GO:0097306 | 3.98% | cellular response to alcohol |
| GO:1901987 | 3.97% | regulation of cell cycle phase transition |
| GO:0060411 | 3.97% | cardiac septum morphogenesis |
| GO:0010717 | 3.97% | regulation of epithelial to mesenchymal transition |
| GO:0030879 | 3.97% | mammary gland development |
| GO:2000679 | 3.96% | positive regulation of transcription regulatory region DNA binding |
| GO:0051963 | 3.95% | regulation of synapse assembly |
| GO:0021700 | 3.95% | developmental maturation |
| GO:0002164 | 3.93% | larval development |
| GO:0034613 | 3.93% | cellular protein localization |
| GO:0010171 | 3.93% | body morphogenesis |
| GO:0032925 | 3.93% | regulation of activin receptor signaling pathway |
| GO:0009636 | 3.91% | response to toxic substance |
| GO:0090049 | 3.91% | regulation of cell migration involved in sprouting angiogenesis |
| GO:0031507 | 3.91% | heterochromatin assembly |
| GO:0097190 | 3.90% | apoptotic signaling pathway |
| GO:0010948 | 3.90% | negative regulation of cell cycle process |
| GO:0002067 | 3.90% | glandular epithelial cell differentiation |
| GO:0044089 | 3.88% | positive regulation of cellular component biogenesis |
| GO:0031099 | 3.88% | regeneration |
| GO:0032886 | 3.87% | regulation of microtubule-based process |
| GO:0044062 | 3.87% | regulation of excretion |
| GO:0007049 | 3.86% | cell cycle |
| GO:0007010 | 3.85% | cytoskeleton organization |
| GO:0044319 | 3.85% | wound healing, spreading of cells |
| GO:0043392 | 3.84% | negative regulation of DNA binding |
| GO:0000904 | 3.83% | cell morphogenesis involved in differentiation |
| GO:0051168 | 3.83% | nuclear export |
| GO:0009607 | 3.83% | response to biotic stimulus |
| GO:0060606 | 3.82% | tube closure |
| GO:0071453 | 3.82% | cellular response to oxygen levels |
| GO:1901992 | 3.82% | positive regulation of mitotic cell cycle phase transition |
| GO:0007026 | 3.81% | negative regulation of microtubule depolymerization |
| GO:0035162 | 3.80% | embryonic hemopoiesis |
| GO:0046903 | 3.80% | secretion |
| GO:0046879 | 3.79% | hormone secretion |
| GO:0031110 | 3.78% | regulation of microtubule polymerization or depolymerization |
| GO:0070828 | 3.77% | heterochromatin organization |
| GO:0008593 | 3.77% | regulation of Notch signaling pathway |
| GO:0043242 | 3.77% | negative regulation of protein complex disassembly |
| GO:0038127 | 3.76% | ERBB signaling pathway |
| GO:0031056 | 3.76% | regulation of histone modification |
| GO:0043525 | 3.75% | positive regulation of neuron apoptotic process |
| GO:0021987 | 3.75% | cerebral cortex development |
| GO:0031349 | 3.75% | positive regulation of defense response |
| GO:0045637 | 3.74% | regulation of myeloid cell differentiation |
| GO:0070507 | 3.74% | regulation of microtubule cytoskeleton organization |
| GO:1901216 | 3.72% | positive regulation of neuron death |
| GO:0044248 | 3.72% | cellular catabolic process |
| GO:0000278 | 3.72% | mitotic cell cycle |
| GO:0030155 | 3.72% | regulation of cell adhesion |
| GO:0048841 | 3.72% | regulation of axon extension involved in axon guidance |
| GO:1903034 | 3.72% | regulation of response to wounding |
| GO:0010971 | 3.72% | positive regulation of G2/M transition of mitotic cell cycle |
| GO:0043537 | 3.71% | negative regulation of blood vessel endothelial cell migration |
| GO:0051091 | 3.71% | positive regulation of DNA-binding transcription factor activity |
| GO:1990830 | 3.71% | cellular response to leukemia inhibitory factor |
| GO:0034504 | 3.71% | protein localization to nucleus |
| GO:0045786 | 3.70% | negative regulation of cell cycle |
| GO:0110148 | 3.70% | biomineralization |
| GO:0002027 | 3.69% | regulation of heart rate |
| GO:0031497 | 3.68% | chromatin assembly |
| GO:0031214 | 3.68% | biomineral tissue development |
| GO:0030031 | 3.68% | cell projection assembly |
| GO:0045646 | 3.67% | regulation of erythrocyte differentiation |
| GO:0031111 | 3.67% | negative regulation of microtubule polymerization or depolymerization |
| GO:0009914 | 3.67% | hormone transport |
| GO:0001843 | 3.66% | neural tube closure |
| GO:0045187 | 3.66% | regulation of circadian sleep/wake cycle, sleep |
| GO:0048048 | 3.65% | embryonic eye morphogenesis |
| GO:0001755 | 3.65% | neural crest cell migration |
| GO:0014014 | 3.64% | negative regulation of gliogenesis |
| GO:0050673 | 3.64% | epithelial cell proliferation |
| GO:1905268 | 3.63% | negative regulation of chromatin organization |
| GO:0048580 | 3.63% | regulation of post-embryonic development |
| GO:0010927 | 3.63% | cellular component assembly involved in morphogenesis |
| GO:0120031 | 3.62% | plasma membrane bounded cell projection assembly |
| GO:0010842 | 3.60% | retina layer formation |
| GO:1990823 | 3.60% | response to leukemia inhibitory factor |
| GO:0042753 | 3.60% | positive regulation of circadian rhythm |
| GO:0016192 | 3.60% | vesicle-mediated transport |
| GO:0035065 | 3.59% | regulation of histone acetylation |
| GO:0006935 | 3.58% | chemotaxis |
| GO:0048520 | 3.58% | positive regulation of behavior |
| GO:0030513 | 3.57% | positive regulation of BMP signaling pathway |
| GO:0072163 | 3.57% | mesonephric epithelium development |
| GO:2000756 | 3.56% | regulation of peptidyl-lysine acetylation |
| GO:1903522 | 3.55% | regulation of blood circulation |
| GO:0032786 | 3.55% | positive regulation of DNA-templated transcription, elongation |
| GO:1902895 | 3.54% | positive regulation of pri-miRNA transcription by RNA polymerase II |
| GO:0010595 | 3.54% | positive regulation of endothelial cell migration |
| GO:0001525 | 3.53% | angiogenesis |
| GO:0006629 | 3.53% | lipid metabolic process |
| GO:1903047 | 3.53% | mitotic cell cycle process |
| GO:0042594 | 3.52% | response to starvation |
| GO:0030325 | 3.52% | adrenal gland development |
| GO:0022610 | 3.51% | biological adhesion |
| GO:0007632 | 3.51% | visual behavior |
| GO:0050764 | 3.50% | regulation of phagocytosis |
| GO:0031057 | 3.50% | negative regulation of histone modification |
| GO:0009755 | 3.50% | hormone-mediated signaling pathway |
| GO:0017145 | 3.50% | stem cell division |
| GO:0061041 | 3.50% | regulation of wound healing |
| GO:0019725 | 3.50% | cellular homeostasis |
| GO:0032940 | 3.48% | secretion by cell |
| GO:0007173 | 3.47% | epidermal growth factor receptor signaling pathway |
| GO:0007635 | 3.45% | chemosensory behavior |
| GO:0051046 | 3.44% | regulation of secretion |
| GO:0001838 | 3.43% | embryonic epithelial tube formation |
| GO:0003151 | 3.43% | outflow tract morphogenesis |
| GO:0051707 | 3.42% | response to other organism |
| GO:0050807 | 3.42% | regulation of synapse organization |
| GO:0072164 | 3.41% | mesonephric tubule development |
| GO:0051100 | 3.41% | negative regulation of binding |
| GO:0051146 | 3.39% | striated muscle cell differentiation |
| GO:0035809 | 3.39% | regulation of urine volume |
| GO:0051494 | 3.38% | negative regulation of cytoskeleton organization |
| GO:0042634 | 3.38% | regulation of hair cycle |
| GO:0003015 | 3.38% | heart process |
| GO:0007164 | 3.37% | establishment of tissue polarity |
| GO:0051897 | 3.37% | positive regulation of protein kinase B signaling |
| GO:0032107 | 3.37% | regulation of response to nutrient levels |
| GO:0048532 | 3.37% | anatomical structure arrangement |
| GO:0051145 | 3.36% | smooth muscle cell differentiation |
| GO:0007155 | 3.35% | cell adhesion |
| GO:0140352 | 3.34% | export from cell |
| GO:0097150 | 3.34% | neuronal stem cell population maintenance |
| GO:0055065 | 3.34% | metal ion homeostasis |
| GO:0050775 | 3.33% | positive regulation of dendrite morphogenesis |
| GO:0022404 | 3.33% | molting cycle process |
| GO:0045746 | 3.33% | negative regulation of Notch signaling pathway |
| GO:0009056 | 3.33% | catabolic process |
| GO:0072594 | 3.33% | establishment of protein localization to organelle |
| GO:0046621 | 3.33% | negative regulation of organ growth |
| GO:0010719 | 3.33% | negative regulation of epithelial to mesenchymal transition |
| GO:0019637 | 3.33% | organophosphate metabolic process |
| GO:0050821 | 3.32% | protein stabilization |
| GO:0001707 | 3.31% | mesoderm formation |
| GO:0002791 | 3.30% | regulation of peptide secretion |
| GO:0060317 | 3.30% | cardiac epithelial to mesenchymal transition |
| GO:1901983 | 3.30% | regulation of protein acetylation |
| GO:1902751 | 3.30% | positive regulation of cell cycle G2/M phase transition |
| GO:0050905 | 3.30% | neuromuscular process |
| GO:2001251 | 3.30% | negative regulation of chromosome organization |
| GO:0048286 | 3.30% | lung alveolus development |
| GO:0006970 | 3.29% | response to osmotic stress |
| GO:0002052 | 3.29% | positive regulation of neuroblast proliferation |
| GO:0042246 | 3.27% | tissue regeneration |
| GO:0090659 | 3.26% | walking behavior |
| GO:0090101 | 3.26% | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0016358 | 3.26% | dendrite development |
| GO:0035914 | 3.26% | skeletal muscle cell differentiation |
| GO:1901564 | 3.26% | organonitrogen compound metabolic process |
| GO:0045766 | 3.25% | positive regulation of angiogenesis |
| GO:0036294 | 3.25% | cellular response to decreased oxygen levels |
| GO:0007568 | 3.24% | aging |
| GO:0032104 | 3.23% | regulation of response to extracellular stimulus |
| GO:0035094 | 3.23% | response to nicotine |
| GO:0048634 | 3.23% | regulation of muscle organ development |
| GO:0098743 | 3.23% | cell aggregation |
| GO:0098771 | 3.22% | inorganic ion homeostasis |
| GO:0005996 | 3.21% | monosaccharide metabolic process |
| GO:0045471 | 3.21% | response to ethanol |
| GO:0034698 | 3.21% | response to gonadotropin |
| GO:0009651 | 3.21% | response to salt stress |
| GO:0032350 | 3.21% | regulation of hormone metabolic process |
| GO:0062012 | 3.21% | regulation of small molecule metabolic process |
| GO:0001659 | 3.20% | temperature homeostasis |
| GO:0032535 | 3.20% | regulation of cellular component size |
| GO:0030512 | 3.19% | negative regulation of transforming growth factor beta receptor signaling pathway |
| GO:0042059 | 3.19% | negative regulation of epidermal growth factor receptor signaling pathway |
| GO:0051170 | 3.18% | import into nucleus |
| GO:0090276 | 3.18% | regulation of peptide hormone secretion |
| GO:0002763 | 3.17% | positive regulation of myeloid leukocyte differentiation |
| GO:1903845 | 3.17% | negative regulation of cellular response to transforming growth factor beta stimulus |
| GO:0036314 | 3.17% | response to sterol |
| GO:0009612 | 3.16% | response to mechanical stimulus |
| GO:0019218 | 3.16% | regulation of steroid metabolic process |
| GO:0050891 | 3.16% | multicellular organismal water homeostasis |
| GO:0030036 | 3.15% | actin cytoskeleton organization |
| GO:0045879 | 3.15% | negative regulation of smoothened signaling pathway |
| GO:0030104 | 3.14% | water homeostasis |
| GO:0071692 | 3.14% | protein localization to extracellular region |
| GO:0046686 | 3.14% | response to cadmium ion |
| GO:0007628 | 3.14% | adult walking behavior |
| GO:0044281 | 3.13% | small molecule metabolic process |
| GO:0045444 | 3.13% | fat cell differentiation |
| GO:0060840 | 3.10% | artery development |
| GO:0032352 | 3.10% | positive regulation of hormone metabolic process |
| GO:0007059 | 3.10% | chromosome segregation |
| GO:1901185 | 3.10% | negative regulation of ERBB signaling pathway |
| GO:0006796 | 3.09% | phosphate-containing compound metabolic process |
| GO:0045638 | 3.09% | negative regulation of myeloid cell differentiation |
| GO:1903530 | 3.09% | regulation of secretion by cell |
| GO:0006793 | 3.08% | phosphorus metabolic process |
| GO:0048168 | 3.08% | regulation of neuronal synaptic plasticity |
| GO:0044703 | 3.08% | multi-organism reproductive process |
| GO:0019318 | 3.08% | hexose metabolic process |
| GO:0048854 | 3.08% | brain morphogenesis |
| GO:0048738 | 3.07% | cardiac muscle tissue development |
| GO:0044030 | 3.07% | regulation of DNA methylation |
| GO:0055080 | 3.06% | cation homeostasis |
| GO:0045814 | 3.06% | negative regulation of gene expression, epigenetic |
| GO:0000226 | 3.05% | microtubule cytoskeleton organization |
| GO:0042440 | 3.05% | pigment metabolic process |
| GO:0030178 | 3.05% | negative regulation of Wnt signaling pathway |
| GO:0043244 | 3.05% | regulation of protein complex disassembly |
| GO:1903671 | 3.05% | negative regulation of sprouting angiogenesis |
| GO:0099402 | 3.05% | plant organ development |
| GO:0001736 | 3.05% | establishment of planar polarity |
| GO:0090288 | 3.04% | negative regulation of cellular response to growth factor stimulus |
| GO:0009649 | 3.04% | entrainment of circadian clock |
| GO:0060260 | 3.04% | regulation of transcription initiation from RNA polymerase II promoter |
| GO:1902107 | 3.04% | positive regulation of leukocyte differentiation |
| GO:0035904 | 3.03% | aorta development |
| GO:0040029 | 3.03% | regulation of gene expression, epigenetic |
| GO:0035592 | 3.02% | establishment of protein localization to extracellular region |
| GO:0055075 | 3.02% | potassium ion homeostasis |
| GO:0006611 | 3.02% | protein export from nucleus |
| GO:0043009 | 3.02% | chordate embryonic development |
| GO:0003073 | 3.01% | regulation of systemic arterial blood pressure |
| GO:0002244 | 3.01% | hematopoietic progenitor cell differentiation |
| GO:0046883 | 3.01% | regulation of hormone secretion |
| GO:0030522 | 3.00% | intracellular receptor signaling pathway |
| GO:1904018 | 3.00% | positive regulation of vasculature development |
| GO:0043536 | 3.00% | positive regulation of blood vessel endothelial cell migration |
| GO:1902850 | 3.00% | microtubule cytoskeleton organization involved in mitosis |
| GO:0003382 | 2.99% | epithelial cell morphogenesis |
| GO:0030073 | 2.98% | insulin secretion |
| GO:1902903 | 2.98% | regulation of supramolecular fiber organization |
| GO:0047484 | 2.98% | regulation of response to osmotic stress |
| GO:0001569 | 2.97% | branching involved in blood vessel morphogenesis |
| GO:1902105 | 2.96% | regulation of leukocyte differentiation |
| GO:0030183 | 2.96% | B cell differentiation |
| GO:0010633 | 2.96% | negative regulation of epithelial cell migration |
| GO:0009850 | 2.96% | auxin metabolic process |
| GO:0097435 | 2.95% | supramolecular fiber organization |
| GO:0045747 | 2.95% | positive regulation of Notch signaling pathway |
| GO:0071371 | 2.95% | cellular response to gonadotropin stimulus |
| GO:0023061 | 2.94% | signal release |
| GO:0034728 | 2.94% | nucleosome organization |
| GO:0055082 | 2.93% | cellular chemical homeostasis |
| GO:0043270 | 2.93% | positive regulation of ion transport |
| GO:1903827 | 2.93% | regulation of cellular protein localization |
| GO:1902074 | 2.93% | response to salt |
| GO:0006403 | 2.93% | RNA localization |
| GO:0001570 | 2.93% | vasculogenesis |
| GO:0003156 | 2.92% | regulation of animal organ formation |
| GO:0006352 | 2.91% | DNA-templated transcription, initiation |
| GO:0050708 | 2.91% | regulation of protein secretion |
| GO:0060261 | 2.90% | positive regulation of transcription initiation from RNA polymerase II promoter |
| GO:0043153 | 2.90% | entrainment of circadian clock by photoperiod |
| GO:0051247 | 2.90% | positive regulation of protein metabolic process |
| GO:0030072 | 2.89% | peptide hormone secretion |
| GO:0042446 | 2.89% | hormone biosynthetic process |
| GO:0010596 | 2.89% | negative regulation of endothelial cell migration |
| GO:0007585 | 2.89% | respiratory gaseous exchange by respiratory system |
| GO:0030101 | 2.89% | natural killer cell activation |
| GO:0050909 | 2.88% | sensory perception of taste |
| GO:0009733 | 2.88% | response to auxin |
| GO:0030029 | 2.88% | actin filament-based process |
| GO:0006353 | 2.87% | DNA-templated transcription, termination |
| GO:0031399 | 2.87% | regulation of protein modification process |
| GO:0045214 | 2.86% | sarcomere organization |
| GO:0051047 | 2.86% | positive regulation of secretion |
| GO:0001701 | 2.86% | in utero embryonic development |
| GO:0022405 | 2.86% | hair cycle process |
| GO:0014812 | 2.85% | muscle cell migration |
| GO:0023014 | 2.85% | signal transduction by protein phosphorylation |
| GO:0051276 | 2.84% | chromosome organization |
| GO:0006873 | 2.83% | cellular ion homeostasis |
| GO:0072507 | 2.83% | divalent inorganic cation homeostasis |
| GO:0007349 | 2.83% | cellularization |
| GO:0002793 | 2.83% | positive regulation of peptide secretion |
| GO:0009267 | 2.83% | cellular response to starvation |
| GO:1904019 | 2.83% | epithelial cell apoptotic process |
| GO:0043114 | 2.82% | regulation of vascular permeability |
| GO:0009648 | 2.82% | photoperiodism |
| GO:1901862 | 2.82% | negative regulation of muscle tissue development |
| GO:1900006 | 2.82% | positive regulation of dendrite development |
| GO:0008286 | 2.81% | insulin receptor signaling pathway |
| GO:0055006 | 2.81% | cardiac cell development |
| GO:0030003 | 2.81% | cellular cation homeostasis |
| GO:0003007 | 2.81% | heart morphogenesis |
| GO:0032868 | 2.81% | response to insulin |
| GO:0055083 | 2.80% | monovalent inorganic anion homeostasis |
| GO:0045662 | 2.80% | negative regulation of myoblast differentiation |
| GO:0007041 | 2.80% | lysosomal transport |
| GO:0007274 | 2.80% | neuromuscular synaptic transmission |
| GO:0006875 | 2.79% | cellular metal ion homeostasis |
| GO:1905207 | 2.79% | regulation of cardiocyte differentiation |
| GO:0071456 | 2.79% | cellular response to hypoxia |
| GO:0044344 | 2.79% | cellular response to fibroblast growth factor stimulus |
| GO:1903707 | 2.79% | negative regulation of hemopoiesis |
| GO:0060415 | 2.79% | muscle tissue morphogenesis |
| GO:0032970 | 2.78% | regulation of actin filament-based process |
| GO:0055007 | 2.78% | cardiac muscle cell differentiation |
| GO:0008333 | 2.77% | endosome to lysosome transport |
| GO:0009306 | 2.77% | protein secretion |
| GO:0030198 | 2.77% | extracellular matrix organization |
| GO:2001020 | 2.76% | regulation of response to DNA damage stimulus |
| GO:0060966 | 2.76% | regulation of gene silencing by RNA |
| GO:0007286 | 2.76% | spermatid development |
| GO:0010506 | 2.76% | regulation of autophagy |
| GO:2000648 | 2.76% | positive regulation of stem cell proliferation |
| GO:0007017 | 2.75% | microtubule-based process |
| GO:0002119 | 2.75% | nematode larval development |
| GO:0070647 | 2.75% | protein modification by small protein conjugation or removal |
| GO:0050796 | 2.74% | regulation of insulin secretion |
| GO:1903844 | 2.74% | regulation of cellular response to transforming growth factor beta stimulus |
| GO:0010771 | 2.74% | negative regulation of cell morphogenesis involved in differentiation |
| GO:0042048 | 2.74% | olfactory behavior |
| GO:0032386 | 2.74% | regulation of intracellular transport |
| GO:0003014 | 2.73% | renal system process |
| GO:1902893 | 2.72% | regulation of pri-miRNA transcription by RNA polymerase II |
| GO:0000165 | 2.72% | MAPK cascade |
| GO:0001657 | 2.72% | ureteric bud development |
| GO:1900046 | 2.71% | regulation of hemostasis |
| GO:0032446 | 2.71% | protein modification by small protein conjugation |
| GO:1903670 | 2.71% | regulation of sprouting angiogenesis |
| GO:0031329 | 2.70% | regulation of cellular catabolic process |
| GO:0008380 | 2.70% | RNA splicing |
| GO:0009950 | 2.69% | dorsal/ventral axis specification |
| GO:0055013 | 2.69% | cardiac muscle cell development |
| GO:0009411 | 2.69% | response to UV |
| GO:0031644 | 2.69% | regulation of nervous system process |
| GO:0031647 | 2.68% | regulation of protein stability |
| GO:1904893 | 2.68% | negative regulation of receptor signaling pathway via STAT |
| GO:0019538 | 2.68% | protein metabolic process |
| GO:0071774 | 2.68% | response to fibroblast growth factor |
| GO:0060004 | 2.66% | reflex |
| GO:0090090 | 2.65% | negative regulation of canonical Wnt signaling pathway |
| GO:0002761 | 2.65% | regulation of myeloid leukocyte differentiation |
| GO:0051017 | 2.64% | actin filament bundle assembly |
| GO:0022411 | 2.64% | cellular component disassembly |
| GO:0043062 | 2.64% | extracellular structure organization |
| GO:1902904 | 2.63% | negative regulation of supramolecular fiber organization |
| GO:0006952 | 2.62% | defense response |
| GO:0009896 | 2.62% | positive regulation of catabolic process |
| GO:0017015 | 2.62% | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0045672 | 2.61% | positive regulation of osteoclast differentiation |
| GO:0034764 | 2.61% | positive regulation of transmembrane transport |
| GO:0006974 | 2.61% | cellular response to DNA damage stimulus |
| GO:1901990 | 2.61% | regulation of mitotic cell cycle phase transition |
| GO:2000142 | 2.61% | regulation of DNA-templated transcription, initiation |
| GO:0061564 | 2.61% | axon development |
| GO:0046677 | 2.61% | response to antibiotic |
| GO:0050900 | 2.61% | leukocyte migration |
| GO:0032270 | 2.60% | positive regulation of cellular protein metabolic process |
| GO:0043412 | 2.60% | macromolecule modification |
| GO:0010827 | 2.60% | regulation of glucose transmembrane transport |
| GO:0071333 | 2.60% | cellular response to glucose stimulus |
| GO:0048013 | 2.60% | ephrin receptor signaling pathway |
| GO:0001101 | 2.60% | response to acid chemical |
| GO:0002790 | 2.60% | peptide secretion |
| GO:0009266 | 2.60% | response to temperature stimulus |
| GO:0046716 | 2.60% | muscle cell cellular homeostasis |
| GO:0034329 | 2.60% | cell junction assembly |
| GO:0034724 | 2.59% | DNA replication-independent nucleosome organization |
| GO:0006275 | 2.59% | regulation of DNA replication |
| GO:0071326 | 2.59% | cellular response to monosaccharide stimulus |
| GO:0051053 | 2.58% | negative regulation of DNA metabolic process |
| GO:0099177 | 2.58% | regulation of trans-synaptic signaling |
| GO:1903532 | 2.58% | positive regulation of secretion by cell |
| GO:0007614 | 2.57% | short-term memory |
| GO:0010661 | 2.57% | positive regulation of muscle cell apoptotic process |
| GO:0006336 | 2.56% | DNA replication-independent nucleosome assembly |
| GO:0060421 | 2.56% | positive regulation of heart growth |
| GO:0006109 | 2.56% | regulation of carbohydrate metabolic process |
| GO:0055008 | 2.56% | cardiac muscle tissue morphogenesis |
| GO:0051222 | 2.56% | positive regulation of protein transport |
| GO:0033574 | 2.56% | response to testosterone |
| GO:0031032 | 2.56% | actomyosin structure organization |
| GO:0072089 | 2.56% | stem cell proliferation |
| GO:0006006 | 2.56% | glucose metabolic process |
| GO:0030098 | 2.56% | lymphocyte differentiation |
| GO:0010038 | 2.55% | response to metal ion |
| GO:0005975 | 2.55% | carbohydrate metabolic process |
| GO:0001947 | 2.55% | heart looping |
| GO:0043627 | 2.55% | response to estrogen |
| GO:0070920 | 2.54% | regulation of production of small RNA involved in gene silencing by RNA |
| GO:0034330 | 2.54% | cell junction organization |
| GO:1901888 | 2.54% | regulation of cell junction assembly |
| GO:1903311 | 2.54% | regulation of mRNA metabolic process |
| GO:0090277 | 2.53% | positive regulation of peptide hormone secretion |
| GO:0045686 | 2.53% | negative regulation of glial cell differentiation |
| GO:0034762 | 2.53% | regulation of transmembrane transport |
| GO:0051147 | 2.53% | regulation of muscle cell differentiation |
| GO:1904951 | 2.53% | positive regulation of establishment of protein localization |
| GO:1903798 | 2.53% | regulation of production of miRNAs involved in gene silencing by miRNA |
| GO:0060147 | 2.52% | regulation of posttranscriptional gene silencing |
| GO:0048831 | 2.52% | regulation of shoot system development |
| GO:0090102 | 2.52% | cochlea development |
| GO:0043254 | 2.52% | regulation of protein complex assembly |
| GO:0071241 | 2.52% | cellular response to inorganic substance |
| GO:0071322 | 2.52% | cellular response to carbohydrate stimulus |
| GO:2001023 | 2.52% | regulation of response to drug |
| GO:0001938 | 2.52% | positive regulation of endothelial cell proliferation |
| GO:0019748 | 2.51% | secondary metabolic process |
| GO:0070897 | 2.50% | transcription preinitiation complex assembly |
| GO:0018205 | 2.50% | peptidyl-lysine modification |
| GO:0021522 | 2.50% | spinal cord motor neuron differentiation |
| GO:0009555 | 2.50% | pollen development |
| GO:0046324 | 2.49% | regulation of glucose import |
| GO:0030217 | 2.49% | T cell differentiation |
| GO:0048635 | 2.49% | negative regulation of muscle organ development |
| GO:0044267 | 2.49% | cellular protein metabolic process |
| GO:0070570 | 2.49% | regulation of neuron projection regeneration |
| GO:0008298 | 2.48% | intracellular mRNA localization |
| GO:0043588 | 2.48% | skin development |
| GO:0055002 | 2.48% | striated muscle cell development |
| GO:0071103 | 2.47% | DNA conformation change |
| GO:0098609 | 2.47% | cell-cell adhesion |
| GO:0071248 | 2.47% | cellular response to metal ion |
| GO:1901861 | 2.47% | regulation of muscle tissue development |
| GO:0045058 | 2.47% | T cell selection |
| GO:0030099 | 2.46% | myeloid cell differentiation |
| GO:0010035 | 2.46% | response to inorganic substance |
| GO:0060627 | 2.46% | regulation of vesicle-mediated transport |
| GO:0071711 | 2.46% | basement membrane organization |
| GO:0042074 | 2.45% | cell migration involved in gastrulation |
| GO:0050801 | 2.45% | ion homeostasis |
| GO:0040036 | 2.45% | regulation of fibroblast growth factor receptor signaling pathway |
| GO:0010718 | 2.45% | positive regulation of epithelial to mesenchymal transition |
| GO:0046649 | 2.45% | lymphocyte activation |
| GO:0008306 | 2.44% | associative learning |
| GO:1905952 | 2.44% | regulation of lipid localization |
| GO:2000144 | 2.43% | positive regulation of DNA-templated transcription, initiation |
| GO:0009894 | 2.43% | regulation of catabolic process |
| GO:0006359 | 2.43% | regulation of transcription by RNA polymerase III |
| GO:0006282 | 2.43% | regulation of DNA repair |
| GO:0030100 | 2.43% | regulation of endocytosis |
| GO:2000737 | 2.42% | negative regulation of stem cell differentiation |
| GO:0048229 | 2.42% | gametophyte development |
| GO:0007160 | 2.42% | cell-matrix adhesion |
| GO:0016071 | 2.41% | mRNA metabolic process |
| GO:1905332 | 2.41% | positive regulation of morphogenesis of an epithelium |
| GO:0042113 | 2.41% | B cell activation |
| GO:0006790 | 2.41% | sulfur compound metabolic process |
| GO:0031331 | 2.41% | positive regulation of cellular catabolic process |
| GO:0030218 | 2.41% | erythrocyte differentiation |
| GO:0043534 | 2.41% | blood vessel endothelial cell migration |
| GO:1905393 | 2.41% | plant organ formation |
| GO:0070830 | 2.41% | bicellular tight junction assembly |
| GO:0032869 | 2.40% | cellular response to insulin stimulus |
| GO:1902806 | 2.40% | regulation of cell cycle G1/S phase transition |
| GO:0031345 | 2.40% | negative regulation of cell projection organization |
| GO:1901655 | 2.40% | cellular response to ketone |
| GO:0000083 | 2.40% | regulation of transcription involved in G1/S transition of mitotic cell cycle |
| GO:0010675 | 2.40% | regulation of cellular carbohydrate metabolic process |
| GO:0006464 | 2.40% | cellular protein modification process |
| GO:0032024 | 2.40% | positive regulation of insulin secretion |
| GO:0008542 | 2.40% | visual learning |
| GO:0045670 | 2.39% | regulation of osteoclast differentiation |
| GO:0036211 | 2.39% | protein modification process |
| GO:0001775 | 2.39% | cell activation |
| GO:0050804 | 2.39% | modulation of chemical synaptic transmission |
| GO:0034285 | 2.39% | response to disaccharide |
| GO:0045843 | 2.38% | negative regulation of striated muscle tissue development |
| GO:0050818 | 2.38% | regulation of coagulation |
| GO:0006259 | 2.38% | DNA metabolic process |
| GO:0060964 | 2.38% | regulation of gene silencing by miRNA |
| GO:1902115 | 2.37% | regulation of organelle assembly |
| GO:0042749 | 2.37% | regulation of circadian sleep/wake cycle |
| GO:0032816 | 2.37% | positive regulation of natural killer cell activation |
| GO:0043620 | 2.37% | regulation of DNA-templated transcription in response to stress |
| GO:0032271 | 2.37% | regulation of protein polymerization |
| GO:0017038 | 2.36% | protein import |
| GO:0060251 | 2.36% | regulation of glial cell proliferation |
| GO:0071331 | 2.36% | cellular response to hexose stimulus |
| GO:0071478 | 2.36% | cellular response to radiation |
| GO:0032984 | 2.36% | protein-containing complex disassembly |
| GO:0046885 | 2.36% | regulation of hormone biosynthetic process |
| GO:0043401 | 2.36% | steroid hormone mediated signaling pathway |
| GO:0003143 | 2.36% | embryonic heart tube morphogenesis |
| GO:0032092 | 2.36% | positive regulation of protein binding |
| GO:0071852 | 2.35% | fungal-type cell wall organization or biogenesis |
| GO:0002062 | 2.34% | chondrocyte differentiation |
| GO:0043618 | 2.34% | regulation of transcription from RNA polymerase II promoter in response to stress |
| GO:0050771 | 2.34% | negative regulation of axonogenesis |
| GO:1903046 | 2.34% | meiotic cell cycle process |
| GO:1901184 | 2.33% | regulation of ERBB signaling pathway |
| GO:0010977 | 2.33% | negative regulation of neuron projection development |
| GO:0097009 | 2.33% | energy homeostasis |
| GO:0051896 | 2.33% | regulation of protein kinase B signaling |
| GO:0002285 | 2.33% | lymphocyte activation involved in immune response |
| GO:0120192 | 2.33% | tight junction assembly |
| GO:0061178 | 2.33% | regulation of insulin secretion involved in cellular response to glucose stimulus |
| GO:0034333 | 2.32% | adherens junction assembly |
| GO:2000758 | 2.32% | positive regulation of peptidyl-lysine acetylation |
| GO:0030447 | 2.32% | filamentous growth |
| GO:0016925 | 2.32% | protein sumoylation |
| GO:0001756 | 2.32% | somitogenesis |
| GO:0033081 | 2.32% | regulation of T cell differentiation in thymus |
| GO:0048636 | 2.32% | positive regulation of muscle organ development |
| GO:2001234 | 2.31% | negative regulation of apoptotic signaling pathway |
| GO:0006997 | 2.31% | nucleus organization |
| GO:0045785 | 2.31% | positive regulation of cell adhesion |
| GO:0048366 | 2.30% | leaf development |
| GO:0042698 | 2.30% | ovulation cycle |
| GO:0032388 | 2.30% | positive regulation of intracellular transport |
| GO:0030193 | 2.30% | regulation of blood coagulation |
| GO:2000377 | 2.30% | regulation of reactive oxygen species metabolic process |
| GO:1900376 | 2.29% | regulation of secondary metabolite biosynthetic process |
| GO:0031069 | 2.29% | hair follicle morphogenesis |
| GO:0021955 | 2.28% | central nervous system neuron axonogenesis |
| GO:0003281 | 2.28% | ventricular septum development |
| GO:0051293 | 2.28% | establishment of spindle localization |
| GO:0050810 | 2.28% | regulation of steroid biosynthetic process |
| GO:0051569 | 2.28% | regulation of histone H3-K4 methylation |
| GO:0042058 | 2.28% | regulation of epidermal growth factor receptor signaling pathway |
| GO:0035150 | 2.28% | regulation of tube size |
| GO:0051781 | 2.28% | positive regulation of cell division |
| GO:0055067 | 2.28% | monovalent inorganic cation homeostasis |
| GO:0008360 | 2.28% | regulation of cell shape |
| GO:0031061 | 2.28% | negative regulation of histone methylation |
| GO:0010828 | 2.27% | positive regulation of glucose transmembrane transport |
| GO:0046605 | 2.27% | regulation of centrosome cycle |
| GO:0009793 | 2.27% | embryo development ending in seed dormancy |
| GO:0045912 | 2.27% | negative regulation of carbohydrate metabolic process |
| GO:0042481 | 2.27% | regulation of odontogenesis |
| GO:0000723 | 2.26% | telomere maintenance |
| GO:0120193 | 2.26% | tight junction organization |
| GO:0009593 | 2.26% | detection of chemical stimulus |
| GO:0061982 | 2.26% | meiosis I cell cycle process |
| GO:0003279 | 2.26% | cardiac septum development |
| GO:2001252 | 2.26% | positive regulation of chromosome organization |
| GO:0031589 | 2.26% | cell-substrate adhesion |
| GO:0003018 | 2.26% | vascular process in circulatory system |
| GO:0043434 | 2.25% | response to peptide hormone |
| GO:1903036 | 2.25% | positive regulation of response to wounding |
| GO:0046887 | 2.24% | positive regulation of hormone secretion |
| GO:0050714 | 2.24% | positive regulation of protein secretion |
| GO:0044182 | 2.24% | filamentous growth of a population of unicellular organisms |
| GO:0006955 | 2.23% | immune response |
| GO:1902930 | 2.23% | regulation of alcohol biosynthetic process |
| GO:0055078 | 2.23% | sodium ion homeostasis |
| GO:0031400 | 2.22% | negative regulation of protein modification process |
| GO:1900151 | 2.22% | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
| GO:0002366 | 2.21% | leukocyte activation involved in immune response |
| GO:0006356 | 2.21% | regulation of transcription by RNA polymerase I |
| GO:2000378 | 2.21% | negative regulation of reactive oxygen species metabolic process |
| GO:0051653 | 2.21% | spindle localization |
| GO:0051341 | 2.21% | regulation of oxidoreductase activity |
| GO:0006979 | 2.20% | response to oxidative stress |
| GO:0048827 | 2.20% | phyllome development |
| GO:0070417 | 2.20% | cellular response to cold |
| GO:0042335 | 2.20% | cuticle development |
| GO:0060674 | 2.20% | placenta blood vessel development |
| GO:0007015 | 2.19% | actin filament organization |
| GO:0007224 | 2.19% | smoothened signaling pathway |
| GO:0034332 | 2.19% | adherens junction organization |
| GO:0097237 | 2.19% | cellular response to toxic substance |
| GO:0010677 | 2.18% | negative regulation of cellular carbohydrate metabolic process |
| GO:0014072 | 2.18% | response to isoquinoline alkaloid |
| GO:0032956 | 2.18% | regulation of actin cytoskeleton organization |
| GO:0045661 | 2.18% | regulation of myoblast differentiation |
| GO:0000086 | 2.17% | G2/M transition of mitotic cell cycle |
| GO:0021915 | 2.17% | neural tube development |
| GO:0001936 | 2.17% | regulation of endothelial cell proliferation |
| GO:0042551 | 2.17% | neuron maturation |
| GO:0071214 | 2.17% | cellular response to abiotic stimulus |
| GO:0040001 | 2.17% | establishment of mitotic spindle localization |
| GO:0030261 | 2.16% | chromosome condensation |
| GO:0009744 | 2.16% | response to sucrose |
| GO:0043436 | 2.16% | oxoacid metabolic process |
| GO:0032273 | 2.16% | positive regulation of protein polymerization |
| GO:0120034 | 2.16% | positive regulation of plasma membrane bounded cell projection assembly |
| GO:0010906 | 2.15% | regulation of glucose metabolic process |
| GO:0045321 | 2.15% | leukocyte activation |
| GO:0042110 | 2.15% | T cell activation |
| GO:0046326 | 2.15% | positive regulation of glucose import |
| GO:0001817 | 2.15% | regulation of cytokine production |
| GO:0060976 | 2.15% | coronary vasculature development |
| GO:0032094 | 2.14% | response to food |
| GO:0008217 | 2.14% | regulation of blood pressure |
| GO:0043486 | 2.14% | histone exchange |
| GO:0071276 | 2.14% | cellular response to cadmium ion |
| GO:0046148 | 2.14% | pigment biosynthetic process |
| GO:0060281 | 2.13% | regulation of oocyte development |
| GO:0014068 | 2.13% | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0030833 | 2.13% | regulation of actin filament polymerization |
| GO:0002200 | 2.13% | somatic diversification of immune receptors |
| GO:0010959 | 2.12% | regulation of metal ion transport |
| GO:0007076 | 2.12% | mitotic chromosome condensation |
| GO:1901890 | 2.12% | positive regulation of cell junction assembly |
| GO:0043269 | 2.12% | regulation of ion transport |
| GO:0019216 | 2.12% | regulation of lipid metabolic process |
| GO:0090329 | 2.12% | regulation of DNA-dependent DNA replication |
| GO:0071559 | 2.12% | response to transforming growth factor beta |
| GO:0008064 | 2.12% | regulation of actin polymerization or depolymerization |
| GO:0006082 | 2.12% | organic acid metabolic process |
| GO:1901796 | 2.12% | regulation of signal transduction by p53 class mediator |
| GO:0044550 | 2.11% | secondary metabolite biosynthetic process |
| GO:0043044 | 2.11% | ATP-dependent chromatin remodeling |
| GO:0001539 | 2.11% | cilium or flagellum-dependent cell motility |
| GO:0045621 | 2.11% | positive regulation of lymphocyte differentiation |
| GO:0030518 | 2.10% | intracellular steroid hormone receptor signaling pathway |
| GO:0035690 | 2.10% | cellular response to drug |
| GO:0030838 | 2.10% | positive regulation of actin filament polymerization |
| GO:0071554 | 2.10% | cell wall organization or biogenesis |
| GO:0104004 | 2.10% | cellular response to environmental stimulus |
| GO:0072503 | 2.09% | cellular divalent inorganic cation homeostasis |
| GO:0002263 | 2.09% | cell activation involved in immune response |
| GO:0032922 | 2.09% | circadian regulation of gene expression |
| GO:0009734 | 2.09% | auxin-activated signaling pathway |
| GO:0009617 | 2.09% | response to bacterium |
| GO:0070726 | 2.09% | cell wall assembly |
| GO:0046916 | 2.09% | cellular transition metal ion homeostasis |
| GO:0031646 | 2.08% | positive regulation of nervous system process |
| GO:1902808 | 2.08% | positive regulation of cell cycle G1/S phase transition |
| GO:0098900 | 2.08% | regulation of action potential |
| GO:0042762 | 2.08% | regulation of sulfur metabolic process |
| GO:1902749 | 2.08% | regulation of cell cycle G2/M phase transition |
| GO:0060285 | 2.08% | cilium-dependent cell motility |
| GO:0016584 | 2.07% | nucleosome positioning |
| GO:0060099 | 2.07% | regulation of phagocytosis, engulfment |
| GO:0035020 | 2.07% | regulation of Rac protein signal transduction |
| GO:1903779 | 2.07% | regulation of cardiac conduction |
| GO:0045740 | 2.07% | positive regulation of DNA replication |
| GO:0009909 | 2.07% | regulation of flower development |
| GO:0071482 | 2.07% | cellular response to light stimulus |
| GO:0006367 | 2.07% | transcription initiation from RNA polymerase II promoter |
| GO:1901652 | 2.07% | response to peptide |
| GO:0001819 | 2.07% | positive regulation of cytokine production |
| GO:0098813 | 2.07% | nuclear chromosome segregation |
| GO:0035188 | 2.07% | hatching |
| GO:0090398 | 2.07% | cellular senescence |
| GO:0001942 | 2.06% | hair follicle development |
| GO:0009860 | 2.06% | pollen tube growth |
| GO:1905562 | 2.06% | regulation of vascular endothelial cell proliferation |
| GO:0007566 | 2.06% | embryo implantation |
| GO:1901566 | 2.06% | organonitrogen compound biosynthetic process |
| GO:0080135 | 2.06% | regulation of cellular response to stress |
| GO:0070783 | 2.06% | growth of unicellular organism as a thread of attached cells |
| GO:0051123 | 2.05% | RNA polymerase II preinitiation complex assembly |
| GO:0033561 | 2.05% | regulation of water loss via skin |
| GO:0010476 | 2.05% | gibberellin mediated signaling pathway |
| GO:0055010 | 2.05% | ventricular cardiac muscle tissue morphogenesis |
| GO:1903831 | 2.05% | signal transduction involved in cellular response to ammonium ion |
| GO:0031060 | 2.05% | regulation of histone methylation |
| GO:0032259 | 2.05% | methylation |
| GO:0060148 | 2.05% | positive regulation of posttranscriptional gene silencing |
| GO:0032200 | 2.04% | telomere organization |
| GO:0033143 | 2.04% | regulation of intracellular steroid hormone receptor signaling pathway |
| GO:0031330 | 2.04% | negative regulation of cellular catabolic process |
| GO:0002286 | 2.04% | T cell activation involved in immune response |
| GO:0009737 | 2.04% | response to abscisic acid |
| GO:0016202 | 2.04% | regulation of striated muscle tissue development |
| GO:0009584 | 2.03% | detection of visible light |
| GO:0048538 | 2.03% | thymus development |
| GO:2000279 | 2.03% | negative regulation of DNA biosynthetic process |
| GO:0048285 | 2.03% | organelle fission |
| GO:0098542 | 2.03% | defense response to other organism |
| GO:0048509 | 2.03% | regulation of meristem development |
| GO:0019915 | 2.03% | lipid storage |
| GO:1901160 | 2.02% | primary amino compound metabolic process |
| GO:0006310 | 2.02% | DNA recombination |
| GO:0097421 | 2.02% | liver regeneration |
| GO:1902253 | 2.02% | regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:0001678 | 2.02% | cellular glucose homeostasis |
| GO:2001025 | 2.01% | positive regulation of response to drug |
| GO:0055074 | 2.01% | calcium ion homeostasis |
| GO:0007616 | 2.01% | long-term memory |
| GO:0009409 | 2.01% | response to cold |
| GO:0007140 | 2.01% | male meiotic nuclear division |
| GO:0071236 | 2.01% | cellular response to antibiotic |
| GO:0061572 | 2.00% | actin filament bundle organization |
| GO:0071417 | 2.00% | cellular response to organonitrogen compound |
| GO:1902533 | 2.00% | positive regulation of intracellular signal transduction |
| GO:0032102 | 2.00% | negative regulation of response to external stimulus |
| GO:0009740 | 2.00% | gibberellic acid mediated signaling pathway |
| GO:0014066 | 1.99% | regulation of phosphatidylinositol 3-kinase signaling |
| GO:0002562 | 1.99% | somatic diversification of immune receptors via germline recombination within a single locus |
| GO:0030832 | 1.99% | regulation of actin filament length |
| GO:0006396 | 1.99% | RNA processing |
| GO:0007051 | 1.99% | spindle organization |
| GO:0030514 | 1.99% | negative regulation of BMP signaling pathway |
| GO:0035813 | 1.98% | regulation of renal sodium excretion |
| GO:0006606 | 1.98% | protein import into nucleus |
| GO:0055076 | 1.98% | transition metal ion homeostasis |
| GO:0060968 | 1.98% | regulation of gene silencing |
| GO:0010592 | 1.98% | positive regulation of lamellipodium assembly |
| GO:2001233 | 1.98% | regulation of apoptotic signaling pathway |
| GO:0033157 | 1.98% | regulation of intracellular protein transport |
| GO:1901985 | 1.98% | positive regulation of protein acetylation |
| GO:0050766 | 1.98% | positive regulation of phagocytosis |
| GO:0007212 | 1.97% | dopamine receptor signaling pathway |
| GO:2000104 | 1.97% | negative regulation of DNA-dependent DNA replication |
| GO:0032649 | 1.97% | regulation of interferon-gamma production |
| GO:1905269 | 1.97% | positive regulation of chromatin organization |
| GO:1901699 | 1.96% | cellular response to nitrogen compound |
| GO:0022413 | 1.96% | reproductive process in single-celled organism |
| GO:0048641 | 1.96% | regulation of skeletal muscle tissue development |
| GO:0070849 | 1.96% | response to epidermal growth factor |
| GO:0033120 | 1.96% | positive regulation of RNA splicing |
| GO:0046697 | 1.96% | decidualization |
| GO:0060420 | 1.96% | regulation of heart growth |
| GO:0010507 | 1.96% | negative regulation of autophagy |
| GO:0060259 | 1.96% | regulation of feeding behavior |
| GO:0051782 | 1.95% | negative regulation of cell division |
| GO:0001824 | 1.95% | blastocyst development |
| GO:0043567 | 1.95% | regulation of insulin-like growth factor receptor signaling pathway |
| GO:0009932 | 1.95% | cell tip growth |
| GO:0007569 | 1.95% | cell aging |
| GO:0034063 | 1.95% | stress granule assembly |
| GO:0098751 | 1.95% | bone cell development |
| GO:0010939 | 1.94% | regulation of necrotic cell death |
| GO:1901617 | 1.94% | organic hydroxy compound biosynthetic process |
| GO:0051051 | 1.94% | negative regulation of transport |
| GO:0030317 | 1.94% | flagellated sperm motility |
| GO:0000280 | 1.94% | nuclear division |
| GO:0048771 | 1.94% | tissue remodeling |
| GO:0045582 | 1.94% | positive regulation of T cell differentiation |
| GO:1901532 | 1.94% | regulation of hematopoietic progenitor cell differentiation |
| GO:0007613 | 1.94% | memory |
| GO:0000018 | 1.93% | regulation of DNA recombination |
| GO:0008610 | 1.93% | lipid biosynthetic process |
| GO:0006638 | 1.93% | neutral lipid metabolic process |
| GO:0045987 | 1.93% | positive regulation of smooth muscle contraction |
| GO:0006639 | 1.93% | acylglycerol metabolic process |
| GO:0010259 | 1.93% | multicellular organism aging |
| GO:0031100 | 1.93% | animal organ regeneration |
| GO:0051321 | 1.93% | meiotic cell cycle |
| GO:0045648 | 1.92% | positive regulation of erythrocyte differentiation |
| GO:1902531 | 1.92% | regulation of intracellular signal transduction |
| GO:0006323 | 1.92% | DNA packaging |
| GO:0043457 | 1.92% | regulation of cellular respiration |
| GO:0034765 | 1.92% | regulation of ion transmembrane transport |
| GO:0048364 | 1.92% | root development |
| GO:0030437 | 1.91% | ascospore formation |
| GO:0060326 | 1.91% | cell chemotaxis |
| GO:0051354 | 1.91% | negative regulation of oxidoreductase activity |
| GO:0044728 | 1.91% | DNA methylation or demethylation |
| GO:0051153 | 1.91% | regulation of striated muscle cell differentiation |
| GO:0035066 | 1.91% | positive regulation of histone acetylation |
| GO:0098657 | 1.90% | import into cell |
| GO:0007638 | 1.90% | mechanosensory behavior |
| GO:0010528 | 1.90% | regulation of transposition |
| GO:0031063 | 1.90% | regulation of histone deacetylation |
| GO:1902991 | 1.90% | regulation of amyloid precursor protein catabolic process |
| GO:0045933 | 1.90% | positive regulation of muscle contraction |
| GO:0016445 | 1.90% | somatic diversification of immunoglobulins |
| GO:2000757 | 1.90% | negative regulation of peptidyl-lysine acetylation |
| GO:0019439 | 1.90% | aromatic compound catabolic process |
| GO:0090303 | 1.90% | positive regulation of wound healing |
| GO:0010029 | 1.89% | regulation of seed germination |
| GO:0001818 | 1.89% | negative regulation of cytokine production |
| GO:0051259 | 1.89% | protein complex oligomerization |
| GO:0051931 | 1.89% | regulation of sensory perception |
| GO:1901984 | 1.89% | negative regulation of protein acetylation |
| GO:0042303 | 1.89% | molting cycle |
| GO:0006468 | 1.89% | protein phosphorylation |
| GO:0002521 | 1.89% | leukocyte differentiation |
| GO:2001242 | 1.89% | regulation of intrinsic apoptotic signaling pathway |
| GO:0030431 | 1.89% | sleep |
| GO:0046631 | 1.88% | alpha-beta T cell activation |
| GO:0030435 | 1.88% | sporulation resulting in formation of a cellular spore |
| GO:1902003 | 1.88% | regulation of amyloid-beta formation |
| GO:0071375 | 1.88% | cellular response to peptide hormone stimulus |
| GO:1902745 | 1.88% | positive regulation of lamellipodium organization |
| GO:0044764 | 1.88% | multi-organism cellular process |
| GO:0019932 | 1.88% | second-messenger-mediated signaling |
| GO:0055088 | 1.88% | lipid homeostasis |
| GO:0006995 | 1.88% | cellular response to nitrogen starvation |
| GO:0044270 | 1.88% | cellular nitrogen compound catabolic process |
| GO:2000637 | 1.87% | positive regulation of gene silencing by miRNA |
| GO:0007043 | 1.87% | cell-cell junction assembly |
| GO:0006304 | 1.87% | DNA modification |
| GO:0090175 | 1.87% | regulation of establishment of planar polarity |
| GO:2000045 | 1.87% | regulation of G1/S transition of mitotic cell cycle |
| GO:0045472 | 1.87% | response to ether |
| GO:0002335 | 1.86% | mature B cell differentiation |
| GO:0032986 | 1.86% | protein-DNA complex disassembly |
| GO:0016310 | 1.86% | phosphorylation |
| GO:0031334 | 1.85% | positive regulation of protein complex assembly |
| GO:0035774 | 1.85% | positive regulation of insulin secretion involved in cellular response to glucose stimulus |
| GO:0009624 | 1.85% | response to nematode |
| GO:0044070 | 1.85% | regulation of anion transport |
| GO:0001541 | 1.85% | ovarian follicle development |
| GO:0051640 | 1.85% | organelle localization |
| GO:0099120 | 1.85% | socially cooperative development |
| GO:0002237 | 1.85% | response to molecule of bacterial origin |
| GO:0043414 | 1.85% | macromolecule methylation |
| GO:0008643 | 1.85% | carbohydrate transport |
| GO:1900140 | 1.84% | regulation of seedling development |
| GO:0050777 | 1.84% | negative regulation of immune response |
| GO:0055070 | 1.84% | copper ion homeostasis |
| GO:1904659 | 1.84% | glucose transmembrane transport |
| GO:0050790 | 1.84% | regulation of catalytic activity |
| GO:0046632 | 1.84% | alpha-beta T cell differentiation |
| GO:0048167 | 1.84% | regulation of synaptic plasticity |
| GO:0002252 | 1.84% | immune effector process |
| GO:0044085 | 1.84% | cellular component biogenesis |
| GO:0043949 | 1.83% | regulation of cAMP-mediated signaling |
| GO:0031641 | 1.83% | regulation of myelination |
| GO:0034110 | 1.83% | regulation of homotypic cell-cell adhesion |
| GO:0006334 | 1.83% | nucleosome assembly |
| GO:0032675 | 1.83% | regulation of interleukin-6 production |
| GO:0043542 | 1.83% | endothelial cell migration |
| GO:0031137 | 1.83% | regulation of conjugation with cellular fusion |
| GO:0097722 | 1.83% | sperm motility |
| GO:0060491 | 1.82% | regulation of cell projection assembly |
| GO:0140013 | 1.82% | meiotic nuclear division |
| GO:0006306 | 1.82% | DNA methylation |
| GO:0043935 | 1.82% | sexual sporulation resulting in formation of a cellular spore |
| GO:0048873 | 1.82% | homeostasis of number of cells within a tissue |
| GO:0010837 | 1.81% | regulation of keratinocyte proliferation |
| GO:0022407 | 1.81% | regulation of cell-cell adhesion |
| GO:0061036 | 1.81% | positive regulation of cartilage development |
| GO:0033688 | 1.81% | regulation of osteoblast proliferation |
| GO:1903312 | 1.81% | negative regulation of mRNA metabolic process |
| GO:0045088 | 1.81% | regulation of innate immune response |
| GO:0009299 | 1.80% | mRNA transcription |
| GO:0000132 | 1.80% | establishment of mitotic spindle orientation |
| GO:0031532 | 1.80% | actin cytoskeleton reorganization |
| GO:0009582 | 1.80% | detection of abiotic stimulus |
| GO:0051965 | 1.80% | positive regulation of synapse assembly |
| GO:0090311 | 1.80% | regulation of protein deacetylation |
| GO:0032814 | 1.80% | regulation of natural killer cell activation |
| GO:0035637 | 1.80% | multicellular organismal signaling |
| GO:0044706 | 1.80% | multi-multicellular organism process |
| GO:0061013 | 1.79% | regulation of mRNA catabolic process |
| GO:0014031 | 1.79% | mesenchymal cell development |
| GO:0051235 | 1.79% | maintenance of location |
| GO:0016444 | 1.79% | somatic cell DNA recombination |
| GO:0006641 | 1.79% | triglyceride metabolic process |
| GO:0010883 | 1.79% | regulation of lipid storage |
| GO:1903429 | 1.79% | regulation of cell maturation |
| GO:0006878 | 1.79% | cellular copper ion homeostasis |
| GO:0120032 | 1.78% | regulation of plasma membrane bounded cell projection assembly |
| GO:0032204 | 1.78% | regulation of telomere maintenance |
| GO:0016567 | 1.78% | protein ubiquitination |
| GO:0009581 | 1.78% | detection of external stimulus |
| GO:0030239 | 1.78% | myofibril assembly |
| GO:0010508 | 1.78% | positive regulation of autophagy |
| GO:0051055 | 1.78% | negative regulation of lipid biosynthetic process |
| GO:0045216 | 1.78% | cell-cell junction organization |
| GO:0031139 | 1.77% | positive regulation of conjugation with cellular fusion |
| GO:1904062 | 1.77% | regulation of cation transmembrane transport |
| GO:0006909 | 1.77% | phagocytosis |
| GO:0032729 | 1.77% | positive regulation of interferon-gamma production |
| GO:0098586 | 1.77% | cellular response to virus |
| GO:0051154 | 1.77% | negative regulation of striated muscle cell differentiation |
| GO:0043934 | 1.77% | sporulation |
| GO:0060706 | 1.77% | cell differentiation involved in embryonic placenta development |
| GO:0018958 | 1.76% | phenol-containing compound metabolic process |
| GO:0072529 | 1.76% | pyrimidine-containing compound catabolic process |
| GO:0048524 | 1.76% | positive regulation of viral process |
| GO:0046700 | 1.76% | heterocycle catabolic process |
| GO:0051606 | 1.76% | detection of stimulus |
| GO:0043278 | 1.76% | response to morphine |
| GO:0009895 | 1.76% | negative regulation of catabolic process |
| GO:0046999 | 1.75% | regulation of conjugation |
| GO:0062014 | 1.75% | negative regulation of small molecule metabolic process |
| GO:0033014 | 1.75% | tetrapyrrole biosynthetic process |
| GO:0045911 | 1.75% | positive regulation of DNA recombination |
| GO:0008361 | 1.75% | regulation of cell size |
| GO:0018193 | 1.75% | peptidyl-amino acid modification |
| GO:2001243 | 1.75% | negative regulation of intrinsic apoptotic signaling pathway |
| GO:0090257 | 1.75% | regulation of muscle system process |
| GO:0046890 | 1.75% | regulation of lipid biosynthetic process |
| GO:0045229 | 1.75% | external encapsulating structure organization |
| GO:0043966 | 1.75% | histone H3 acetylation |
| GO:0033189 | 1.75% | response to vitamin A |
| GO:0006694 | 1.74% | steroid biosynthetic process |
| GO:0045739 | 1.74% | positive regulation of DNA repair |
| GO:0055081 | 1.74% | anion homeostasis |
| GO:0080154 | 1.74% | regulation of fertilization |
| GO:0070670 | 1.74% | response to interleukin-4 |
| GO:1903313 | 1.73% | positive regulation of mRNA metabolic process |
| GO:0008630 | 1.73% | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0045601 | 1.73% | regulation of endothelial cell differentiation |
| GO:0031136 | 1.73% | positive regulation of conjugation |
| GO:0072527 | 1.72% | pyrimidine-containing compound metabolic process |
| GO:1905153 | 1.72% | regulation of membrane invagination |
| GO:0018195 | 1.72% | peptidyl-arginine modification |
| GO:0098901 | 1.72% | regulation of cardiac muscle cell action potential |
| GO:0051188 | 1.72% | cofactor biosynthetic process |
| GO:0016053 | 1.72% | organic acid biosynthetic process |
| GO:0009404 | 1.72% | toxin metabolic process |
| GO:1902905 | 1.72% | positive regulation of supramolecular fiber organization |
| GO:1903053 | 1.72% | regulation of extracellular matrix organization |
| GO:1902170 | 1.72% | cellular response to reactive nitrogen species |
| GO:0006879 | 1.72% | cellular iron ion homeostasis |
| GO:0007044 | 1.71% | cell-substrate junction assembly |
| GO:0032570 | 1.71% | response to progesterone |
| GO:0098801 | 1.71% | regulation of renal system process |
| GO:0008645 | 1.71% | hexose transmembrane transport |
| GO:1902993 | 1.71% | positive regulation of amyloid precursor protein catabolic process |
| GO:0015749 | 1.71% | monosaccharide transmembrane transport |
| GO:2000024 | 1.71% | regulation of leaf development |
| GO:0044772 | 1.71% | mitotic cell cycle phase transition |
| GO:1900087 | 1.71% | positive regulation of G1/S transition of mitotic cell cycle |
| GO:0045132 | 1.71% | meiotic chromosome segregation |
| GO:0045943 | 1.70% | positive regulation of transcription by RNA polymerase I |
| GO:0007097 | 1.70% | nuclear migration |
| GO:0010575 | 1.70% | positive regulation of vascular endothelial growth factor production |
| GO:0002698 | 1.70% | negative regulation of immune effector process |
| GO:0032206 | 1.70% | positive regulation of telomere maintenance |
| GO:1904892 | 1.70% | regulation of receptor signaling pathway via STAT |
| GO:0051930 | 1.70% | regulation of sensory perception of pain |
| GO:0001776 | 1.70% | leukocyte homeostasis |
| GO:0033013 | 1.70% | tetrapyrrole metabolic process |
| GO:0031102 | 1.69% | neuron projection regeneration |
| GO:0044283 | 1.69% | small molecule biosynthetic process |
| GO:0043562 | 1.69% | cellular response to nitrogen levels |
| GO:0071555 | 1.69% | cell wall organization |
| GO:0006631 | 1.69% | fatty acid metabolic process |
| GO:0001944 | 1.69% | vasculature development |
| GO:0048821 | 1.69% | erythrocyte development |
| GO:0046683 | 1.68% | response to organophosphorus |
| GO:2000826 | 1.68% | regulation of heart morphogenesis |
| GO:0032755 | 1.68% | positive regulation of interleukin-6 production |
| GO:0007162 | 1.68% | negative regulation of cell adhesion |
| GO:0006473 | 1.68% | protein acetylation |
| GO:0043903 | 1.68% | regulation of symbiosis, encompassing mutualism through parasitism |
| GO:0051148 | 1.68% | negative regulation of muscle cell differentiation |
| GO:0031505 | 1.68% | fungal-type cell wall organization |
| GO:0002209 | 1.67% | behavioral defense response |
| GO:0030587 | 1.67% | sorocarp development |
| GO:0019752 | 1.67% | carboxylic acid metabolic process |
| GO:0046394 | 1.67% | carboxylic acid biosynthetic process |
| GO:0050921 | 1.67% | positive regulation of chemotaxis |
| GO:0033077 | 1.67% | T cell differentiation in thymus |
| GO:2000036 | 1.66% | regulation of stem cell population maintenance |
| GO:1905508 | 1.66% | protein localization to microtubule organizing center |
| GO:0032787 | 1.66% | monocarboxylic acid metabolic process |
| GO:0050994 | 1.66% | regulation of lipid catabolic process |
| GO:0014741 | 1.66% | negative regulation of muscle hypertrophy |
| GO:1901135 | 1.66% | carbohydrate derivative metabolic process |
| GO:0031058 | 1.66% | positive regulation of histone modification |
| GO:0042789 | 1.66% | mRNA transcription by RNA polymerase II |
| GO:0070542 | 1.66% | response to fatty acid |
| GO:0043086 | 1.66% | negative regulation of catalytic activity |
| GO:0050792 | 1.65% | regulation of viral process |
| GO:0061014 | 1.65% | positive regulation of mRNA catabolic process |
| GO:0098534 | 1.65% | centriole assembly |
| GO:0061337 | 1.65% | cardiac conduction |
| GO:1900026 | 1.65% | positive regulation of substrate adhesion-dependent cell spreading |
| GO:0070997 | 1.65% | neuron death |
| GO:1901797 | 1.65% | negative regulation of signal transduction by p53 class mediator |
| GO:0000003 | 1.65% | reproduction |
| GO:1901419 | 1.64% | regulation of response to alcohol |
| GO:0050918 | 1.64% | positive chemotaxis |
| GO:0034219 | 1.64% | carbohydrate transmembrane transport |
| GO:0071470 | 1.64% | cellular response to osmotic stress |
| GO:0010087 | 1.64% | phloem or xylem histogenesis |
| GO:0034766 | 1.64% | negative regulation of ion transmembrane transport |
| GO:0019221 | 1.64% | cytokine-mediated signaling pathway |
| GO:0044770 | 1.64% | cell cycle phase transition |
| GO:0009583 | 1.64% | detection of light stimulus |
| GO:0045910 | 1.64% | negative regulation of DNA recombination |
| GO:0016036 | 1.64% | cellular response to phosphate starvation |
| GO:0010669 | 1.64% | epithelial structure maintenance |
| GO:0045930 | 1.63% | negative regulation of mitotic cell cycle |
| GO:0043467 | 1.63% | regulation of generation of precursor metabolites and energy |
| GO:0009415 | 1.63% | response to water |
| GO:0002312 | 1.63% | B cell activation involved in immune response |
| GO:0090702 | 1.63% | non-reproductive fruiting body development |
| GO:0009414 | 1.63% | response to water deprivation |
| GO:0007127 | 1.63% | meiosis I |
| GO:0051647 | 1.63% | nucleus localization |
| GO:0034502 | 1.63% | protein localization to chromosome |
| GO:0071398 | 1.62% | cellular response to fatty acid |
| GO:0009268 | 1.62% | response to pH |
| GO:0032651 | 1.62% | regulation of interleukin-1 beta production |
| GO:0030199 | 1.62% | collagen fibril organization |
| GO:0010574 | 1.62% | regulation of vascular endothelial growth factor production |
| GO:0048545 | 1.62% | response to steroid hormone |
| GO:0045663 | 1.62% | positive regulation of myoblast differentiation |
| GO:0034763 | 1.62% | negative regulation of transmembrane transport |
| GO:0046189 | 1.62% | phenol-containing compound biosynthetic process |
| GO:0051260 | 1.62% | protein homooligomerization |
| GO:0043951 | 1.62% | negative regulation of cAMP-mediated signaling |
| GO:0070816 | 1.62% | phosphorylation of RNA polymerase II C-terminal domain |
| GO:0032467 | 1.61% | positive regulation of cytokinesis |
| GO:0071869 | 1.61% | response to catecholamine |
| GO:0006940 | 1.61% | regulation of smooth muscle contraction |
| GO:0043200 | 1.61% | response to amino acid |
| GO:0043455 | 1.61% | regulation of secondary metabolic process |
| GO:0034293 | 1.60% | sexual sporulation |
| GO:0010389 | 1.60% | regulation of G2/M transition of mitotic cell cycle |
| GO:0044419 | 1.60% | interspecies interaction between organisms |
| GO:0046579 | 1.60% | positive regulation of Ras protein signal transduction |
| GO:0016573 | 1.60% | histone acetylation |
| GO:0032496 | 1.59% | response to lipopolysaccharide |
| GO:0008156 | 1.59% | negative regulation of DNA replication |
| GO:0045862 | 1.59% | positive regulation of proteolysis |
| GO:0009408 | 1.59% | response to heat |
| GO:1902743 | 1.59% | regulation of lamellipodium organization |
| GO:0006783 | 1.59% | heme biosynthetic process |
| GO:0044843 | 1.59% | cell cycle G1/S phase transition |
| GO:1905957 | 1.59% | regulation of cellular response to alcohol |
| GO:0006446 | 1.59% | regulation of translational initiation |
| GO:0006959 | 1.59% | humoral immune response |
| GO:0014032 | 1.58% | neural crest cell development |
| GO:1901615 | 1.58% | organic hydroxy compound metabolic process |
| GO:0002028 | 1.58% | regulation of sodium ion transport |
| GO:0006508 | 1.58% | proteolysis |
| GO:0008299 | 1.58% | isoprenoid biosynthetic process |
| GO:0050684 | 1.57% | regulation of mRNA processing |
| GO:0045087 | 1.57% | innate immune response |
| GO:0006778 | 1.57% | porphyrin-containing compound metabolic process |
| GO:0051592 | 1.57% | response to calcium ion |
| GO:0045992 | 1.57% | negative regulation of embryonic development |
| GO:0051402 | 1.57% | neuron apoptotic process |
| GO:0018394 | 1.57% | peptidyl-lysine acetylation |
| GO:0016571 | 1.57% | histone methylation |
| GO:0008206 | 1.57% | bile acid metabolic process |
| GO:1903421 | 1.57% | regulation of synaptic vesicle recycling |
| GO:0006305 | 1.57% | DNA alkylation |
| GO:1904035 | 1.57% | regulation of epithelial cell apoptotic process |
| GO:0022408 | 1.56% | negative regulation of cell-cell adhesion |
| GO:2000278 | 1.56% | regulation of DNA biosynthetic process |
| GO:1903010 | 1.56% | regulation of bone development |
| GO:0007595 | 1.56% | lactation |
| GO:1901653 | 1.56% | cellular response to peptide |
| GO:0048741 | 1.56% | skeletal muscle fiber development |
| GO:0090698 | 1.55% | post-embryonic plant morphogenesis |
| GO:0010332 | 1.55% | response to gamma radiation |
| GO:0044839 | 1.55% | cell cycle G2/M phase transition |
| GO:0001961 | 1.55% | positive regulation of cytokine-mediated signaling pathway |
| GO:0045807 | 1.55% | positive regulation of endocytosis |
| GO:0019933 | 1.55% | cAMP-mediated signaling |
| GO:0046486 | 1.55% | glycerolipid metabolic process |
| GO:0006779 | 1.55% | porphyrin-containing compound biosynthetic process |
| GO:0051604 | 1.55% | protein maturation |
| GO:0010591 | 1.55% | regulation of lamellipodium assembly |
| GO:0051294 | 1.55% | establishment of spindle orientation |
| GO:0048581 | 1.55% | negative regulation of post-embryonic development |
| GO:0007141 | 1.54% | male meiosis I |
| GO:0009630 | 1.54% | gravitropism |
| GO:0051495 | 1.54% | positive regulation of cytoskeleton organization |
| GO:0071168 | 1.54% | protein localization to chromatin |
| GO:0048747 | 1.54% | muscle fiber development |
| GO:0071229 | 1.54% | cellular response to acid chemical |
| GO:0035924 | 1.54% | cellular response to vascular endothelial growth factor stimulus |
| GO:0032890 | 1.54% | regulation of organic acid transport |
| GO:0016447 | 1.53% | somatic recombination of immunoglobulin gene segments |
| GO:0051591 | 1.53% | response to cAMP |
| GO:0006475 | 1.53% | internal protein amino acid acetylation |
| GO:0009845 | 1.53% | seed germination |
| GO:1900024 | 1.53% | regulation of substrate adhesion-dependent cell spreading |
| GO:0035902 | 1.53% | response to immobilization stress |
| GO:0007589 | 1.53% | body fluid secretion |
| GO:0043543 | 1.52% | protein acylation |
| GO:0045833 | 1.52% | negative regulation of lipid metabolic process |
| GO:0060412 | 1.52% | ventricular septum morphogenesis |
| GO:0045494 | 1.52% | photoreceptor cell maintenance |
| GO:0090316 | 1.52% | positive regulation of intracellular protein transport |
| GO:0061117 | 1.52% | negative regulation of heart growth |
| GO:0033144 | 1.52% | negative regulation of intracellular steroid hormone receptor signaling pathway |
| GO:2000273 | 1.52% | positive regulation of signaling receptor activity |
| GO:0006479 | 1.52% | protein methylation |
| GO:0014074 | 1.51% | response to purine-containing compound |
| GO:0009615 | 1.51% | response to virus |
| GO:0050686 | 1.51% | negative regulation of mRNA processing |
| GO:0032642 | 1.51% | regulation of chemokine production |
| GO:0051338 | 1.51% | regulation of transferase activity |
| GO:0051262 | 1.51% | protein tetramerization |
| GO:0070167 | 1.51% | regulation of biomineral tissue development |
| GO:0046425 | 1.51% | regulation of receptor signaling pathway via JAK-STAT |
| GO:0090567 | 1.51% | reproductive shoot system development |
| GO:0048367 | 1.51% | shoot system development |
| GO:0060760 | 1.51% | positive regulation of response to cytokine stimulus |
| GO:0016032 | 1.51% | viral process |
| GO:0022409 | 1.51% | positive regulation of cell-cell adhesion |
| GO:0097327 | 1.51% | response to antineoplastic agent |
| GO:0010830 | 1.51% | regulation of myotube differentiation |
| GO:1903317 | 1.51% | regulation of protein maturation |
| GO:0016241 | 1.50% | regulation of macroautophagy |
| GO:0042435 | 1.50% | indole-containing compound biosynthetic process |
| GO:0031440 | 1.50% | regulation of mRNA 3'-end processing |
| GO:0010811 | 1.50% | positive regulation of cell-substrate adhesion |
| GO:0007608 | 1.50% | sensory perception of smell |
| GO:0018393 | 1.50% | internal peptidyl-lysine acetylation |
| GO:0097066 | 1.50% | response to thyroid hormone |
| GO:0008213 | 1.50% | protein alkylation |
| GO:0070098 | 1.50% | chemokine-mediated signaling pathway |
| GO:1905392 | 1.49% | plant organ morphogenesis |
| GO:0045619 | 1.49% | regulation of lymphocyte differentiation |
| GO:1900180 | 1.49% | regulation of protein localization to nucleus |
| GO:0071560 | 1.49% | cellular response to transforming growth factor beta stimulus |
| GO:0050680 | 1.49% | negative regulation of epithelial cell proliferation |
| GO:0010660 | 1.49% | regulation of muscle cell apoptotic process |
| GO:0009867 | 1.49% | jasmonic acid mediated signaling pathway |
| GO:0016114 | 1.49% | terpenoid biosynthetic process |
| GO:0002292 | 1.49% | T cell differentiation involved in immune response |
| GO:0055072 | 1.48% | iron ion homeostasis |
| GO:0110053 | 1.48% | regulation of actin filament organization |
| GO:0006720 | 1.48% | isoprenoid metabolic process |
| GO:0009606 | 1.48% | tropism |
| GO:0010821 | 1.48% | regulation of mitochondrion organization |
| GO:0055026 | 1.48% | negative regulation of cardiac muscle tissue development |
| GO:1903319 | 1.48% | positive regulation of protein maturation |
| GO:0003179 | 1.47% | heart valve morphogenesis |
| GO:0002762 | 1.47% | negative regulation of myeloid leukocyte differentiation |
| GO:0030002 | 1.47% | cellular anion homeostasis |
| GO:1903829 | 1.47% | positive regulation of cellular protein localization |
| GO:0051057 | 1.47% | positive regulation of small GTPase mediated signal transduction |
| GO:1904036 | 1.47% | negative regulation of epithelial cell apoptotic process |
| GO:0006368 | 1.47% | transcription elongation from RNA polymerase II promoter |
| GO:1902117 | 1.47% | positive regulation of organelle assembly |
| GO:0045744 | 1.47% | negative regulation of G protein-coupled receptor signaling pathway |
| GO:0035418 | 1.47% | protein localization to synapse |
| GO:0021510 | 1.47% | spinal cord development |
| GO:0006897 | 1.47% | endocytosis |
| GO:0097696 | 1.47% | receptor signaling pathway via STAT |
| GO:2000765 | 1.47% | regulation of cytoplasmic translation |
| GO:0010662 | 1.47% | regulation of striated muscle cell apoptotic process |
| GO:0050867 | 1.46% | positive regulation of cell activation |
| GO:0007096 | 1.46% | regulation of exit from mitosis |
| GO:0032409 | 1.46% | regulation of transporter activity |
| GO:0071459 | 1.46% | protein localization to chromosome, centromeric region |
| GO:0000387 | 1.46% | spliceosomal snRNP assembly |
| GO:0061515 | 1.46% | myeloid cell development |
| GO:0030162 | 1.46% | regulation of proteolysis |
| GO:0001835 | 1.46% | blastocyst hatching |
| GO:2001038 | 1.46% | regulation of cellular response to drug |
| GO:0071867 | 1.46% | response to monoamine |
| GO:0042742 | 1.46% | defense response to bacterium |
| GO:0006882 | 1.46% | cellular zinc ion homeostasis |
| GO:0032368 | 1.45% | regulation of lipid transport |
| GO:0000381 | 1.45% | regulation of alternative mRNA splicing, via spliceosome |
| GO:0034754 | 1.45% | cellular hormone metabolic process |
| GO:0042770 | 1.45% | signal transduction in response to DNA damage |
| GO:0006354 | 1.45% | DNA-templated transcription, elongation |
| GO:0014003 | 1.45% | oligodendrocyte development |
| GO:0007259 | 1.45% | receptor signaling pathway via JAK-STAT |
| GO:1901863 | 1.45% | positive regulation of muscle tissue development |
| GO:0042168 | 1.45% | heme metabolic process |
| GO:0055022 | 1.45% | negative regulation of cardiac muscle tissue growth |
| GO:0048259 | 1.45% | regulation of receptor-mediated endocytosis |
| GO:0045948 | 1.45% | positive regulation of translational initiation |
| GO:0006721 | 1.45% | terpenoid metabolic process |
| GO:0035330 | 1.45% | regulation of hippo signaling |
| GO:0006584 | 1.44% | catecholamine metabolic process |
| GO:0000212 | 1.44% | meiotic spindle organization |
| GO:0006858 | 1.44% | extracellular transport |
| GO:1901998 | 1.44% | toxin transport |
| GO:0002040 | 1.44% | sprouting angiogenesis |
| GO:0032465 | 1.44% | regulation of cytokinesis |
| GO:0033146 | 1.44% | regulation of intracellular estrogen receptor signaling pathway |
| GO:0090207 | 1.43% | regulation of triglyceride metabolic process |
| GO:0006874 | 1.43% | cellular calcium ion homeostasis |
| GO:0031348 | 1.43% | negative regulation of defense response |
| GO:0071941 | 1.42% | nitrogen cycle metabolic process |
| GO:0009642 | 1.42% | response to light intensity |
| GO:0032480 | 1.42% | negative regulation of type I interferon production |
| GO:0010393 | 1.42% | galacturonan metabolic process |
| GO:0032954 | 1.42% | regulation of cytokinetic process |
| GO:0051225 | 1.42% | spindle assembly |
| GO:1903320 | 1.41% | regulation of protein modification by small protein conjugation or removal |
| GO:0071277 | 1.41% | cellular response to calcium ion |
| GO:0010665 | 1.41% | regulation of cardiac muscle cell apoptotic process |
| GO:0019935 | 1.41% | cyclic-nucleotide-mediated signaling |
| GO:0061436 | 1.41% | establishment of skin barrier |
| GO:0045921 | 1.41% | positive regulation of exocytosis |
| GO:0010565 | 1.41% | regulation of cellular ketone metabolic process |
| GO:0006406 | 1.41% | mRNA export from nucleus |
| GO:0034103 | 1.41% | regulation of tissue remodeling |
| GO:0009712 | 1.40% | catechol-containing compound metabolic process |
| GO:0051928 | 1.40% | positive regulation of calcium ion transport |
| GO:0042133 | 1.40% | neurotransmitter metabolic process |
| GO:0000082 | 1.40% | G1/S transition of mitotic cell cycle |
| GO:0032652 | 1.40% | regulation of interleukin-1 production |
| GO:1902373 | 1.39% | negative regulation of mRNA catabolic process |
| GO:0018023 | 1.39% | peptidyl-lysine trimethylation |
| GO:0048024 | 1.39% | regulation of mRNA splicing, via spliceosome |
| GO:1902369 | 1.38% | negative regulation of RNA catabolic process |
| GO:0016458 | 1.38% | gene silencing |
| GO:0031103 | 1.38% | axon regeneration |
| GO:0050805 | 1.38% | negative regulation of synaptic transmission |
| GO:0045776 | 1.38% | negative regulation of blood pressure |
| GO:0043570 | 1.38% | maintenance of DNA repeat elements |
| GO:0045580 | 1.38% | regulation of T cell differentiation |
| GO:0034655 | 1.38% | nucleobase-containing compound catabolic process |
| GO:0050829 | 1.38% | defense response to Gram-negative bacterium |
| GO:0051571 | 1.38% | positive regulation of histone H3-K4 methylation |
| GO:0007005 | 1.38% | mitochondrion organization |
| GO:0010614 | 1.37% | negative regulation of cardiac muscle hypertrophy |
| GO:0033273 | 1.37% | response to vitamin |
| GO:1903998 | 1.37% | regulation of eating behavior |
| GO:0034644 | 1.37% | cellular response to UV |
| GO:1901988 | 1.37% | negative regulation of cell cycle phase transition |
| GO:0045010 | 1.37% | actin nucleation |
| GO:0032680 | 1.37% | regulation of tumor necrosis factor production |
| GO:0016485 | 1.37% | protein processing |
| GO:0006939 | 1.37% | smooth muscle contraction |
| GO:0048017 | 1.37% | inositol lipid-mediated signaling |
| GO:0042546 | 1.37% | cell wall biogenesis |
| GO:0001974 | 1.37% | blood vessel remodeling |
| GO:0043367 | 1.36% | CD4-positive, alpha-beta T cell differentiation |
| GO:0030330 | 1.36% | DNA damage response, signal transduction by p53 class mediator |
| GO:0016973 | 1.36% | poly(A)+ mRNA export from nucleus |
| GO:0051261 | 1.36% | protein depolymerization |
| GO:0044247 | 1.36% | cellular polysaccharide catabolic process |
| GO:0048284 | 1.36% | organelle fusion |
| GO:0000302 | 1.36% | response to reactive oxygen species |
| GO:0032967 | 1.36% | positive regulation of collagen biosynthetic process |
| GO:1901361 | 1.36% | organic cyclic compound catabolic process |
| GO:0002696 | 1.36% | positive regulation of leukocyte activation |
| GO:0051251 | 1.36% | positive regulation of lymphocyte activation |
| GO:0014904 | 1.36% | myotube cell development |
| GO:0060135 | 1.36% | maternal process involved in female pregnancy |
| GO:0050727 | 1.36% | regulation of inflammatory response |
| GO:0022618 | 1.36% | ribonucleoprotein complex assembly |
| GO:0010831 | 1.35% | positive regulation of myotube differentiation |
| GO:0032924 | 1.35% | activin receptor signaling pathway |
| GO:0043484 | 1.35% | regulation of RNA splicing |
| GO:1904994 | 1.35% | regulation of leukocyte adhesion to vascular endothelial cell |
| GO:0016482 | 1.35% | cytosolic transport |
| GO:0035821 | 1.35% | modification of morphology or physiology of other organism |
| GO:0000725 | 1.35% | recombinational repair |
| GO:0009908 | 1.35% | flower development |
| GO:0071353 | 1.35% | cellular response to interleukin-4 |
| GO:0051491 | 1.34% | positive regulation of filopodium assembly |
| GO:2001244 | 1.34% | positive regulation of intrinsic apoptotic signaling pathway |
| GO:0002825 | 1.34% | regulation of T-helper 1 type immune response |
| GO:2001022 | 1.34% | positive regulation of response to DNA damage stimulus |
| GO:0006405 | 1.34% | RNA export from nucleus |
| GO:0003206 | 1.34% | cardiac chamber morphogenesis |
| GO:0033206 | 1.34% | meiotic cytokinesis |
| GO:0006954 | 1.33% | inflammatory response |
| GO:0044403 | 1.33% | symbiotic process |
| GO:0010765 | 1.33% | positive regulation of sodium ion transport |
| GO:0006397 | 1.32% | mRNA processing |
| GO:0032655 | 1.32% | regulation of interleukin-12 production |
| GO:0048678 | 1.32% | response to axon injury |
| GO:0031023 | 1.32% | microtubule organizing center organization |
| GO:0043500 | 1.32% | muscle adaptation |
| GO:0034389 | 1.32% | lipid droplet organization |
| GO:0010286 | 1.32% | heat acclimation |
| GO:0006888 | 1.32% | endoplasmic reticulum to Golgi vesicle-mediated transport |
| GO:0016570 | 1.31% | histone modification |
| GO:0045488 | 1.31% | pectin metabolic process |
| GO:0045793 | 1.31% | positive regulation of cell size |
| GO:0022600 | 1.31% | digestive system process |
| GO:0046824 | 1.31% | positive regulation of nucleocytoplasmic transport |
| GO:0009738 | 1.31% | abscisic acid-activated signaling pathway |
| GO:0000041 | 1.31% | transition metal ion transport |
| GO:0016441 | 1.31% | posttranscriptional gene silencing |
| GO:0110149 | 1.31% | regulation of biomineralization |
| GO:1902042 | 1.30% | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0046782 | 1.30% | regulation of viral transcription |
| GO:0031333 | 1.30% | negative regulation of protein complex assembly |
| GO:0036003 | 1.30% | positive regulation of transcription from RNA polymerase II promoter in response to stress |
| GO:0009620 | 1.30% | response to fungus |
| GO:0042596 | 1.30% | fear response |
| GO:0050870 | 1.30% | positive regulation of T cell activation |
| GO:0051056 | 1.30% | regulation of small GTPase mediated signal transduction |
| GO:1903039 | 1.29% | positive regulation of leukocyte cell-cell adhesion |
| GO:0051817 | 1.29% | modification of morphology or physiology of other organism involved in symbiotic interaction |
| GO:0051851 | 1.29% | modification by host of symbiont morphology or physiology |
| GO:0043549 | 1.29% | regulation of kinase activity |
| GO:0033628 | 1.29% | regulation of cell adhesion mediated by integrin |
| GO:0034599 | 1.29% | cellular response to oxidative stress |
| GO:0035710 | 1.29% | CD4-positive, alpha-beta T cell activation |
| GO:0031401 | 1.29% | positive regulation of protein modification process |
| GO:1904591 | 1.29% | positive regulation of protein import |
| GO:0034968 | 1.29% | histone lysine methylation |
| GO:0042254 | 1.29% | ribosome biogenesis |
| GO:0060967 | 1.29% | negative regulation of gene silencing by RNA |
| GO:0035510 | 1.29% | DNA dealkylation |
| GO:0051489 | 1.29% | regulation of filopodium assembly |
| GO:0043624 | 1.28% | cellular protein complex disassembly |
| GO:0097581 | 1.28% | lamellipodium organization |
| GO:0001562 | 1.28% | response to protozoan |
| GO:0048147 | 1.28% | negative regulation of fibroblast proliferation |
| GO:0034694 | 1.28% | response to prostaglandin |
| GO:0035296 | 1.28% | regulation of tube diameter |
| GO:0016569 | 1.28% | covalent chromatin modification |
| GO:0006268 | 1.28% | DNA unwinding involved in DNA replication |
| GO:0042542 | 1.28% | response to hydrogen peroxide |
| GO:2001236 | 1.28% | regulation of extrinsic apoptotic signaling pathway |
| GO:0018022 | 1.28% | peptidyl-lysine methylation |
| GO:0034440 | 1.27% | lipid oxidation |
| GO:0030316 | 1.27% | osteoclast differentiation |
| GO:0014896 | 1.27% | muscle hypertrophy |
| GO:0071479 | 1.27% | cellular response to ionizing radiation |
| GO:0015918 | 1.27% | sterol transport |
| GO:2000134 | 1.27% | negative regulation of G1/S transition of mitotic cell cycle |
| GO:0001672 | 1.27% | regulation of chromatin assembly or disassembly |
| GO:0031156 | 1.27% | regulation of sorocarp development |
| GO:0046578 | 1.27% | regulation of Ras protein signal transduction |
| GO:0006401 | 1.27% | RNA catabolic process |
| GO:0060969 | 1.27% | negative regulation of gene silencing |
| GO:0030318 | 1.27% | melanocyte differentiation |
| GO:2000191 | 1.26% | regulation of fatty acid transport |
| GO:0098630 | 1.26% | aggregation of unicellular organisms |
| GO:0007052 | 1.26% | mitotic spindle organization |
| GO:1903524 | 1.26% | positive regulation of blood circulation |
| GO:0045823 | 1.26% | positive regulation of heart contraction |
| GO:0014888 | 1.26% | striated muscle adaptation |
| GO:0006022 | 1.26% | aminoglycan metabolic process |
| GO:1903555 | 1.26% | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0071468 | 1.26% | cellular response to acidic pH |
| GO:0007189 | 1.26% | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO:0032411 | 1.26% | positive regulation of transporter activity |
| GO:1903338 | 1.25% | regulation of cell wall organization or biogenesis |
| GO:0016101 | 1.25% | diterpenoid metabolic process |
| GO:0002573 | 1.25% | myeloid leukocyte differentiation |
| GO:0051249 | 1.25% | regulation of lymphocyte activation |
| GO:0051649 | 1.25% | establishment of localization in cell |
| GO:0048169 | 1.25% | regulation of long-term neuronal synaptic plasticity |
| GO:0071480 | 1.25% | cellular response to gamma radiation |
| GO:0051149 | 1.25% | positive regulation of muscle cell differentiation |
| GO:0001662 | 1.25% | behavioral fear response |
| GO:1901575 | 1.25% | organic substance catabolic process |
| GO:0051702 | 1.24% | interaction with symbiont |
| GO:0043487 | 1.24% | regulation of RNA stability |
| GO:1903427 | 1.24% | negative regulation of reactive oxygen species biosynthetic process |
| GO:0055024 | 1.24% | regulation of cardiac muscle tissue development |
| GO:0017157 | 1.24% | regulation of exocytosis |
| GO:0051656 | 1.24% | establishment of organelle localization |
| GO:0070192 | 1.24% | chromosome organization involved in meiotic cell cycle |
| GO:0050728 | 1.24% | negative regulation of inflammatory response |
| GO:0001885 | 1.24% | endothelial cell development |
| GO:0003012 | 1.24% | muscle system process |
| GO:0000724 | 1.23% | double-strand break repair via homologous recombination |
| GO:0048261 | 1.23% | negative regulation of receptor-mediated endocytosis |
| GO:0071467 | 1.23% | cellular response to pH |
| GO:0010039 | 1.23% | response to iron ion |
| GO:0030032 | 1.23% | lamellipodium assembly |
| GO:0071364 | 1.23% | cellular response to epidermal growth factor stimulus |
| GO:0006826 | 1.23% | iron ion transport |
| GO:1903959 | 1.23% | regulation of anion transmembrane transport |
| GO:0042326 | 1.23% | negative regulation of phosphorylation |
| GO:0034614 | 1.23% | cellular response to reactive oxygen species |
| GO:1902106 | 1.23% | negative regulation of leukocyte differentiation |
| GO:0010043 | 1.23% | response to zinc ion |
| GO:0090312 | 1.22% | positive regulation of protein deacetylation |
| GO:0035082 | 1.22% | axoneme assembly |
| GO:0007602 | 1.22% | phototransduction |
| GO:0031065 | 1.22% | positive regulation of histone deacetylation |
| GO:1903793 | 1.22% | positive regulation of anion transport |
| GO:0002828 | 1.22% | regulation of type 2 immune response |
| GO:0030168 | 1.22% | platelet activation |
| GO:0006937 | 1.22% | regulation of muscle contraction |
| GO:0051048 | 1.22% | negative regulation of secretion |
| GO:0055021 | 1.22% | regulation of cardiac muscle tissue growth |
| GO:0060045 | 1.22% | positive regulation of cardiac muscle cell proliferation |
| GO:0051291 | 1.22% | protein heterooligomerization |
| GO:0106070 | 1.22% | regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO:0006342 | 1.22% | chromatin silencing |
| GO:0051193 | 1.22% | regulation of cofactor metabolic process |
| GO:0042307 | 1.22% | positive regulation of protein import into nucleus |
| GO:0032731 | 1.21% | positive regulation of interleukin-1 beta production |
| GO:0050873 | 1.21% | brown fat cell differentiation |
| GO:0014743 | 1.21% | regulation of muscle hypertrophy |
| GO:0120161 | 1.21% | regulation of cold-induced thermogenesis |
| GO:0006633 | 1.21% | fatty acid biosynthetic process |
| GO:0016574 | 1.21% | histone ubiquitination |
| GO:0002821 | 1.21% | positive regulation of adaptive immune response |
| GO:0031960 | 1.21% | response to corticosteroid |
| GO:0042423 | 1.21% | catecholamine biosynthetic process |
| GO:0051125 | 1.21% | regulation of actin nucleation |
| GO:0044060 | 1.20% | regulation of endocrine process |
| GO:0016578 | 1.20% | histone deubiquitination |
| GO:0009753 | 1.20% | response to jasmonic acid |
| GO:1902019 | 1.20% | regulation of cilium-dependent cell motility |
| GO:0031113 | 1.20% | regulation of microtubule polymerization |
| GO:0060149 | 1.20% | negative regulation of posttranscriptional gene silencing |
| GO:0071514 | 1.20% | genetic imprinting |
| GO:0051186 | 1.20% | cofactor metabolic process |
| GO:0010714 | 1.20% | positive regulation of collagen metabolic process |
| GO:0009637 | 1.20% | response to blue light |
| GO:2000779 | 1.20% | regulation of double-strand break repair |
| GO:0032732 | 1.20% | positive regulation of interleukin-1 production |
| GO:0002360 | 1.20% | T cell lineage commitment |
| GO:0048193 | 1.20% | Golgi vesicle transport |
| GO:0002824 | 1.20% | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0032272 | 1.20% | negative regulation of protein polymerization |
| GO:0009308 | 1.19% | amine metabolic process |
| GO:0007288 | 1.19% | sperm axoneme assembly |
| GO:0022898 | 1.19% | regulation of transmembrane transporter activity |
| GO:0072698 | 1.19% | protein localization to microtubule cytoskeleton |
| GO:0045453 | 1.19% | bone resorption |
| GO:0032410 | 1.19% | negative regulation of transporter activity |
| GO:0010228 | 1.19% | vegetative to reproductive phase transition of meristem |
| GO:0050885 | 1.19% | neuromuscular process controlling balance |
| GO:0016102 | 1.18% | diterpenoid biosynthetic process |
| GO:0009251 | 1.18% | glucan catabolic process |
| GO:0048643 | 1.18% | positive regulation of skeletal muscle tissue development |
| GO:0032768 | 1.18% | regulation of monooxygenase activity |
| GO:0043652 | 1.18% | engulfment of apoptotic cell |
| GO:0046635 | 1.18% | positive regulation of alpha-beta T cell activation |
| GO:1903533 | 1.18% | regulation of protein targeting |
| GO:0051155 | 1.17% | positive regulation of striated muscle cell differentiation |
| GO:0034401 | 1.17% | chromatin organization involved in regulation of transcription |
| GO:0010894 | 1.17% | negative regulation of steroid biosynthetic process |
| GO:0071472 | 1.17% | cellular response to salt stress |
| GO:0046822 | 1.17% | regulation of nucleocytoplasmic transport |
| GO:1900182 | 1.17% | positive regulation of protein localization to nucleus |
| GO:0042430 | 1.17% | indole-containing compound metabolic process |
| GO:0031062 | 1.17% | positive regulation of histone methylation |
| GO:1905209 | 1.17% | positive regulation of cardiocyte differentiation |
| GO:0045844 | 1.17% | positive regulation of striated muscle tissue development |
| GO:0060043 | 1.17% | regulation of cardiac muscle cell proliferation |
| GO:0048026 | 1.16% | positive regulation of mRNA splicing, via spliceosome |
| GO:0010410 | 1.16% | hemicellulose metabolic process |
| GO:0019226 | 1.16% | transmission of nerve impulse |
| GO:1902414 | 1.16% | protein localization to cell junction |
| GO:0050931 | 1.16% | pigment cell differentiation |
| GO:0071826 | 1.16% | ribonucleoprotein complex subunit organization |
| GO:0070301 | 1.16% | cellular response to hydrogen peroxide |
| GO:0045936 | 1.16% | negative regulation of phosphate metabolic process |
| GO:0051384 | 1.16% | response to glucocorticoid |
| GO:0010563 | 1.16% | negative regulation of phosphorus metabolic process |
| GO:0007033 | 1.16% | vacuole organization |
| GO:0008277 | 1.16% | regulation of G protein-coupled receptor signaling pathway |
| GO:0043488 | 1.16% | regulation of mRNA stability |
| GO:0009657 | 1.16% | plastid organization |
| GO:1990928 | 1.15% | response to amino acid starvation |
| GO:0045600 | 1.15% | positive regulation of fat cell differentiation |
| GO:0050854 | 1.15% | regulation of antigen receptor-mediated signaling pathway |
| GO:0098926 | 1.15% | postsynaptic signal transduction |
| GO:0061037 | 1.15% | negative regulation of cartilage development |
| GO:0098693 | 1.15% | regulation of synaptic vesicle cycle |
| GO:1905897 | 1.15% | regulation of response to endoplasmic reticulum stress |
| GO:1904063 | 1.15% | negative regulation of cation transmembrane transport |
| GO:0032526 | 1.15% | response to retinoic acid |
| GO:0007064 | 1.14% | mitotic sister chromatid cohesion |
| GO:0043489 | 1.14% | RNA stabilization |
| GO:0034198 | 1.14% | cellular response to amino acid starvation |
| GO:0031935 | 1.14% | regulation of chromatin silencing |
| GO:0048010 | 1.14% | vascular endothelial growth factor receptor signaling pathway |
| GO:0009832 | 1.14% | plant-type cell wall biogenesis |
| GO:2000573 | 1.14% | positive regulation of DNA biosynthetic process |
| GO:0042403 | 1.14% | thyroid hormone metabolic process |
| GO:0009713 | 1.14% | catechol-containing compound biosynthetic process |
| GO:0060142 | 1.14% | regulation of syncytium formation by plasma membrane fusion |
| GO:0032722 | 1.13% | positive regulation of chemokine production |
| GO:0015908 | 1.13% | fatty acid transport |
| GO:0030865 | 1.13% | cortical cytoskeleton organization |
| GO:0001556 | 1.13% | oocyte maturation |
| GO:0050907 | 1.13% | detection of chemical stimulus involved in sensory perception |
| GO:1900117 | 1.13% | regulation of execution phase of apoptosis |
| GO:0032760 | 1.13% | positive regulation of tumor necrosis factor production |
| GO:0044272 | 1.13% | sulfur compound biosynthetic process |
| GO:0050996 | 1.13% | positive regulation of lipid catabolic process |
| GO:1901607 | 1.13% | alpha-amino acid biosynthetic process |
| GO:0034104 | 1.13% | negative regulation of tissue remodeling |
| GO:0097746 | 1.13% | regulation of blood vessel diameter |
| GO:0010611 | 1.13% | regulation of cardiac muscle hypertrophy |
| GO:0045939 | 1.12% | negative regulation of steroid metabolic process |
| GO:0048015 | 1.12% | phosphatidylinositol-mediated signaling |
| GO:1904589 | 1.12% | regulation of protein import |
| GO:2001237 | 1.12% | negative regulation of extrinsic apoptotic signaling pathway |
| GO:0002694 | 1.12% | regulation of leukocyte activation |
| GO:0033555 | 1.12% | multicellular organismal response to stress |
| GO:0030001 | 1.12% | metal ion transport |
| GO:0006402 | 1.12% | mRNA catabolic process |
| GO:0048311 | 1.12% | mitochondrion distribution |
| GO:0033233 | 1.12% | regulation of protein sumoylation |
| GO:0016540 | 1.12% | protein autoprocessing |
| GO:0071216 | 1.12% | cellular response to biotic stimulus |
| GO:0051016 | 1.12% | barbed-end actin filament capping |
| GO:0055069 | 1.11% | zinc ion homeostasis |
| GO:0006906 | 1.11% | vesicle fusion |
| GO:0009451 | 1.11% | RNA modification |
| GO:0000398 | 1.11% | mRNA splicing, via spliceosome |
| GO:0050911 | 1.11% | detection of chemical stimulus involved in sensory perception of smell |
| GO:0019344 | 1.11% | cysteine biosynthetic process |
| GO:0070168 | 1.11% | negative regulation of biomineral tissue development |
| GO:0030007 | 1.11% | cellular potassium ion homeostasis |
| GO:0071731 | 1.11% | response to nitric oxide |
| GO:2001021 | 1.11% | negative regulation of response to DNA damage stimulus |
| GO:0031396 | 1.11% | regulation of protein ubiquitination |
| GO:0042119 | 1.11% | neutrophil activation |
| GO:0030511 | 1.11% | positive regulation of transforming growth factor beta receptor signaling pathway |
| GO:0019954 | 1.10% | asexual reproduction |
| GO:0043967 | 1.10% | histone H4 acetylation |
| GO:0050919 | 1.10% | negative chemotaxis |
| GO:0050863 | 1.10% | regulation of T cell activation |
| GO:0003341 | 1.10% | cilium movement |
| GO:1903578 | 1.10% | regulation of ATP metabolic process |
| GO:1902807 | 1.10% | negative regulation of cell cycle G1/S phase transition |
| GO:0032965 | 1.10% | regulation of collagen biosynthetic process |
| GO:0030500 | 1.10% | regulation of bone mineralization |
| GO:0000002 | 1.10% | mitochondrial genome maintenance |
| GO:0031152 | 1.10% | aggregation involved in sorocarp development |
| GO:0010212 | 1.09% | response to ionizing radiation |
| GO:0070988 | 1.09% | demethylation |
| GO:1902041 | 1.09% | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0030517 | 1.09% | negative regulation of axon extension |
| GO:0060998 | 1.09% | regulation of dendritic spine development |
| GO:0002437 | 1.09% | inflammatory response to antigenic stimulus |
| GO:0006012 | 1.09% | galactose metabolic process |
| GO:0098781 | 1.09% | ncRNA transcription |
| GO:0095500 | 1.09% | acetylcholine receptor signaling pathway |
| GO:0043372 | 1.09% | positive regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0030010 | 1.09% | establishment of cell polarity |
| GO:0009988 | 1.09% | cell-cell recognition |
| GO:0110151 | 1.08% | positive regulation of biomineralization |
| GO:0048255 | 1.08% | mRNA stabilization |
| GO:0006376 | 1.08% | mRNA splice site selection |
| GO:0016239 | 1.08% | positive regulation of macroautophagy |
| GO:0009812 | 1.08% | flavonoid metabolic process |
| GO:0002250 | 1.08% | adaptive immune response |
| GO:0010559 | 1.08% | regulation of glycoprotein biosynthetic process |
| GO:0034767 | 1.08% | positive regulation of ion transmembrane transport |
| GO:0120162 | 1.08% | positive regulation of cold-induced thermogenesis |
| GO:0007020 | 1.08% | microtubule nucleation |
| GO:0007188 | 1.08% | adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
| GO:0048661 | 1.08% | positive regulation of smooth muscle cell proliferation |
| GO:0051952 | 1.08% | regulation of amine transport |
| GO:0042771 | 1.08% | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| GO:0006582 | 1.08% | melanin metabolic process |
| GO:0042128 | 1.08% | nitrate assimilation |
| GO:0014065 | 1.07% | phosphatidylinositol 3-kinase signaling |
| GO:0000160 | 1.07% | phosphorelay signal transduction system |
| GO:1903846 | 1.07% | positive regulation of cellular response to transforming growth factor beta stimulus |
| GO:0071870 | 1.07% | cellular response to catecholamine stimulus |
| GO:0007030 | 1.07% | Golgi organization |
| GO:0009057 | 1.07% | macromolecule catabolic process |
| GO:0019220 | 1.07% | regulation of phosphate metabolic process |
| GO:0014850 | 1.07% | response to muscle activity |
| GO:0042325 | 1.07% | regulation of phosphorylation |
| GO:0010824 | 1.07% | regulation of centrosome duplication |
| GO:0048660 | 1.07% | regulation of smooth muscle cell proliferation |
| GO:0055085 | 1.07% | transmembrane transport |
| GO:0048145 | 1.06% | regulation of fibroblast proliferation |
| GO:0043268 | 1.06% | positive regulation of potassium ion transport |
| GO:0010469 | 1.06% | regulation of signaling receptor activity |
| GO:0042391 | 1.06% | regulation of membrane potential |
| GO:0060079 | 1.06% | excitatory postsynaptic potential |
| GO:0022613 | 1.06% | ribonucleoprotein complex biogenesis |
| GO:0032088 | 1.06% | negative regulation of NF-kappaB transcription factor activity |
| GO:0032508 | 1.06% | DNA duplex unwinding |
| GO:1902017 | 1.06% | regulation of cilium assembly |
| GO:0045839 | 1.06% | negative regulation of mitotic nuclear division |
| GO:0086091 | 1.06% | regulation of heart rate by cardiac conduction |
| GO:0006575 | 1.06% | cellular modified amino acid metabolic process |
| GO:0044458 | 1.05% | motile cilium assembly |
| GO:0042832 | 1.05% | defense response to protozoan |
| GO:0007131 | 1.05% | reciprocal meiotic recombination |
| GO:0002832 | 1.05% | negative regulation of response to biotic stimulus |
| GO:1902532 | 1.05% | negative regulation of intracellular signal transduction |
| GO:0032673 | 1.05% | regulation of interleukin-4 production |
| GO:0110150 | 1.05% | negative regulation of biomineralization |
| GO:0050848 | 1.05% | regulation of calcium-mediated signaling |
| GO:1990778 | 1.05% | protein localization to cell periphery |
| GO:1901657 | 1.05% | glycosyl compound metabolic process |
| GO:0055023 | 1.05% | positive regulation of cardiac muscle tissue growth |
| GO:0051973 | 1.05% | positive regulation of telomerase activity |
| GO:0061024 | 1.05% | membrane organization |
| GO:0009086 | 1.05% | methionine biosynthetic process |
| GO:0051289 | 1.04% | protein homotetramerization |
| GO:0002090 | 1.04% | regulation of receptor internalization |
| GO:0071875 | 1.04% | adrenergic receptor signaling pathway |
| GO:0070613 | 1.04% | regulation of protein processing |
| GO:0042136 | 1.04% | neurotransmitter biosynthetic process |
| GO:0034695 | 1.04% | response to prostaglandin E |
| GO:0031288 | 1.04% | sorocarp morphogenesis |
| GO:1901222 | 1.04% | regulation of NIK/NF-kappaB signaling |
| GO:0055025 | 1.04% | positive regulation of cardiac muscle tissue development |
| GO:2001239 | 1.04% | regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0010150 | 1.04% | leaf senescence |
| GO:0007062 | 1.03% | sister chromatid cohesion |
| GO:0019730 | 1.03% | antimicrobial humoral response |
| GO:1901991 | 1.03% | negative regulation of mitotic cell cycle phase transition |
| GO:0051693 | 1.03% | actin filament capping |
| GO:0051174 | 1.03% | regulation of phosphorus metabolic process |
| GO:0042306 | 1.03% | regulation of protein import into nucleus |
| GO:0071320 | 1.03% | cellular response to cAMP |
| GO:2000171 | 1.03% | negative regulation of dendrite development |
| GO:1905954 | 1.03% | positive regulation of lipid localization |
| GO:1901099 | 1.03% | negative regulation of signal transduction in absence of ligand |
| GO:0060999 | 1.03% | positive regulation of dendritic spine development |
| GO:0032392 | 1.02% | DNA geometric change |
| GO:0010226 | 1.02% | response to lithium ion |
| GO:0030947 | 1.02% | regulation of vascular endothelial growth factor receptor signaling pathway |
| GO:1903018 | 1.02% | regulation of glycoprotein metabolic process |
| GO:0044265 | 1.02% | cellular macromolecule catabolic process |
| GO:0055114 | 1.02% | oxidation-reduction process |
| GO:0003351 | 1.02% | epithelial cilium movement involved in extracellular fluid movement |
| GO:0032479 | 1.02% | regulation of type I interferon production |
| GO:0097549 | 1.02% | chromatin organization involved in negative regulation of transcription |
| GO:0043901 | 1.02% | negative regulation of multi-organism process |
| GO:0070371 | 1.02% | ERK1 and ERK2 cascade |
| GO:0071868 | 1.02% | cellular response to monoamine stimulus |
| GO:0030501 | 1.02% | positive regulation of bone mineralization |
| GO:0032412 | 1.02% | regulation of ion transmembrane transporter activity |
| GO:0019217 | 1.02% | regulation of fatty acid metabolic process |
| GO:0071669 | 1.02% | plant-type cell wall organization or biogenesis |
| GO:0006936 | 1.02% | muscle contraction |
| GO:0008652 | 1.02% | cellular amino acid biosynthetic process |
| GO:0030835 | 1.02% | negative regulation of actin filament depolymerization |
| GO:0010712 | 1.01% | regulation of collagen metabolic process |
| GO:1903509 | 1.01% | liposaccharide metabolic process |
| GO:0051403 | 1.01% | stress-activated MAPK cascade |
| GO:0038179 | 1.01% | neurotrophin signaling pathway |
| GO:0006664 | 1.01% | glycolipid metabolic process |
| GO:0030728 | 1.01% | ovulation |
| GO:0045732 | 1.01% | positive regulation of protein catabolic process |
| GO:1903037 | 1.01% | regulation of leukocyte cell-cell adhesion |
| GO:2000105 | 1.01% | positive regulation of DNA-dependent DNA replication |
| GO:0090174 | 1.01% | organelle membrane fusion |
| GO:0010569 | 1.01% | regulation of double-strand break repair via homologous recombination |
| GO:0071383 | 1.01% | cellular response to steroid hormone stimulus |
| GO:0010447 | 1.01% | response to acidic pH |
| GO:0030301 | 1.01% | cholesterol transport |
| GO:1902473 | 1.01% | regulation of protein localization to synapse |
| GO:0051279 | 1.01% | regulation of release of sequestered calcium ion into cytosol |
| GO:0000375 | 1.00% | RNA splicing, via transesterification reactions |
| GO:0006910 | 1.00% | phagocytosis, recognition |
| GO:0007187 | 1.00% | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0009723 | 1.00% | response to ethylene |
| GO:0045724 | 1.00% | positive regulation of cilium assembly |
| GO:0043502 | 1.00% | regulation of muscle adaptation |
| GO:0045671 | 1.00% | negative regulation of osteoclast differentiation |
| GO:0071466 | 1.00% | cellular response to xenobiotic stimulus |
| GO:0031343 | 1.00% | positive regulation of cell killing |